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Direct-to-consumer genomics (DTCG) health testing offers great promise to 
humanity, however to date adoption has lagged as a result of consumer awareness, 
understanding, and previous government regulations restricting DTCG companies from 
providing information on an individual’s genetic predispositions. But in 2017 the broader 
DTCG market which also includes genealogical testing demonstrated exponential 
growth, implying that DTCG is starting to diffuse as an innovation. To better understand 
the sociocultural forces affecting diffusion, adoption, and satisfaction, qualitative 
ethnographic research was conducted with DTCG genealogy and health consumers. 
The data was qualitatively analyzed using thematic analysis to understand the 
similarities and differences in beliefs, attitudes, intentions, and mediating factors that 
have influenced consumers. Design anthropology theory and methods were used to 
produce ethnographically informed insights. The insights were then translated into 
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Genomics, or the study of all of the genetic information of a species, is a field of 
science that has far-reaching applications in medicine, biotechnology, anthropology and 
other social sciences (Barnes and Dupré 2008). Since the completion of the Human 
Genome Project (HGP) in 2003, genomics has been touted by the medical and 
biotechnology community as having the potential to “enable medical researchers to 
develop improved diagnostics, more effective therapeutic strategies, evidence-based 
approaches for demonstrating clinical efficacy, and better decision-making tools for 
patients and providers” (National Human Genome Research Institute 2015, para. 15). 
However, adoption within clinical settings has been slow given that most physicians 
have limited genetics and genomics education and training in their undergraduate and 
graduate educational programs and clinical training (National Human Genome 
Research Institute n.d.). To address this gap in the market, private companies have 
started to sell genetic testing directly to consumers. This model, known as Direct-to-
Consumer genetics (DTCG), is progressing more rapidly than genomics in the clinical 
setting, but it too is still in its infancy.  
In 2017 the number of people who have taken a DTCG test nearly doubled 
compared to 2016, pushing the total number somewhere close to an estimated 12 
million (MIT Technology Review 2018).  However, not all of the growth is for health 
purposes. In fact, the majority of the growth is happening for genealogical reasons led 
by Ancestry’s DTCG test. AncestryDNA was released in 2012, and in the first three 
years of business within the genetic genealogy space, Ancestry sequenced over one 
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million partial genomes. Since 2015, AncestryDNA has grown exponentially. As of April 
2017, Ancestry had reached 4 million users, with a fourth of the genomes being 
sequenced between January and April of that year (Ancestry 2017). On November 6, 
2017, they posted on their website that they had reached 6 million genomes in the DNA 
database (Ancestry 2017). Then, as if the previous growth wasn’t impressive enough, 
they sold roughly 1.5 million kits in quarter four of 2017, about triple the same period of 
the prior year, putting them somewhere above 7.5 million genomes in their database, 
which would represent about 62% of the total DTCG US market. (Forbes 2017).   
But all of this growth, impressive as it is, does not help achieve the hopes and 
dreams of the medical community because only a fraction of the US population has 
taken a genetic health test.  In fact, in a 2016 UBS Securities LLC survey of 1,000 
people representative of the US population, they found that only 5 percent said they had 
been tested on their initiative, and 50 percent said they were likely not to get tested 
(UBS Securities LLC 2016). Similarly, in a 2016 Rock Health survey, 36 percent of 
consumer respondents stated they had not taken a genetic health test because there is 
"no need" and another 27 percent because they are "unaware or need more 
information" (Rock Health 2016, 21). However, the ever-increasing popularity of 
genealogy DTCG tests points seems to imply that there is a market in the making for 
genetic health testing. The question is, therefore, why, how, and when will consumers 
adopt DTCG health tests? 
To explore this question, I conducted remote ethnographic research with 
consumers who have previously used DTCG genealogical tests, and those who have 
used DTCG health tests through Sequencing.com. The data was collected through 
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qualitative research sessions that involved phone-based semi-structured interviews for 
genealogical consumers and screen sharing-based interviews and observations for 
Sequencing.com users. The data was coded using thematic analysis and analyzed in 
the context of theories from anthropology, sociology, communication, and information 
systems that have been used historically to understand the diffusion and adoption 
process. The theoretical frameworks and models leveraged in this study include, but are 
not limited to, the Diffusion of Innovations Theory, the Technology Acceptance Model, 
communication flow models, and theories related to disruptive innovations.  
The qualitative data was mapped to these theories to specifically understand the 
beliefs, attitudes, behavioral intentions, and other motivating factors that influenced 
adoption. The theories were also leveraged to gauge other dimensions of the diffusion 
and adoption process as it relates to perceived usefulness, ease of use, and risk. 
Furthermore, the research sought to build on these findings by defining the persona of 
current adopters. Finally, the research sought to identify gaps in the product offering, 
with the objective of developing some potential features for a product roadmap.  The 
goal of these objectives was to produce actionable ethnographically informed insights 
that Sequencing.com can use to define their target market and create a whole product 
concept, that is mutually beneficial to their business model, as well the consumers that 





The following chapter provides background information about the client, 
Sequencing.com, their need, the deliverables, the research process and how I came to 
work with Sequencing.com. I will then situate their need in the broader sociocultural 
context by discussing the history of DTCG market for both genealogy and health. I will 
close by discussing some of the concerns raised by the science community in the 
context of recent changes to the regulations that govern the DTCG market. 
2.1 The Client: Sequencing.com 
Sequencing.com is a software platform and application (app) marketplace that 
allows users to upload, store, and analyze genetic data, including partial and full 
genomes. Sequencing.com was created with the goal of making genetic information 
accessible to the world by making genetic code incredibly easy to work with and 
understand (Sequencing.com 2018). To accomplish this, the platform allows users to 
upload genetic data. The data can come from any DTCG testing service such as 
Ancestry.com, 23andMe, and FamilyTreeDNA, as well as from clinical labs.  
Users are then able to analyze their genetic information using apps that were 
either created by Sequencing.com or other third-party app developers who have 
published their apps in the Sequencing.com app marketplace.  The apps that 
Sequencing.com created produce results that are directly accessible from within the 
platform, while the apps that other developers created often require the users to create 
an account at the producer’s website to retrieve their results.  The apps are either free 
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or have a cost. The apps which have a cost associated with them may have a one-time 
fee or a per use fee. Costs range from $0.99 to several hundred dollars. 
Currently there are 46 apps, making Sequencing.com the largest app 
marketplace for genetic testing. The apps are classified into eight categories: 
bioinformatics, clinical, enterprise and lab, research, mobile, app development, 
education, and wellness. The bioinformatics, clinical, enterprise and lab, and research 
apps are quite niche oriented as they are primarily targeted to individuals with a 
background in genetics. This is best illustrated by the names of the apps, which include 
examples such as Imputation Analysis, Convert rsids to Coordinates, Variant Effect 
Predictor, and BowTie2 Aligner.  The apps in the mobile and app development category 
are targeted at app developers as proofs-of-concept (POC) for building apps on top of 
genetic data, but could be utilized by any user of Sequencing.com.  The one app in the 
education category is a genealogy app, which again could be used by all users.  Lastly, 
there is the wellness category which can easily target all users of the platform be it a 
bioinformatician, healthcare professional, or a consumer, but it is the most targeted to 
the consumer category. This is best illustrated by some of the app names which include 
Wellness and Longevity, Healthy Heart, Skin Health Optimizer, Age with Strength, Male 
Pattern Baldness, and Arthritis Prevention.  
Some of the apps run directly within the platform such as those created by 
Sequencing.com, while others run elsewhere. For the apps that run elsewhere, they 
could be accessible as web apps or mobile apps for use on mobile devices, such as 
phones, tablets, or watches.  When the apps are running outside of the 
Sequencing.com platform, they make use of the Real-Time PersonalizationTM (RTP) 
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technology which is an application programming interface (API) that allows app 
developers to pull genetic data from Sequencing.com, assuming an authorized 
purchase was made by a Sequencing.com customer. If RTP is used, app developers 
can simply analyze the genetic data to produce results, or they are able to combine 
other real-time data with the genomic data to produce customized recommendations to 
the consumer.  This latter point is illustrated by one of the mobile app POCs 
Sequencing.com developed. The app is called Weather My Way + RTP, and combines 
real-time weather data with genetic data related to skin and cancer. The app works by 
locating the consumer geographically based on the geo-coordinates of their mobile 
device, checking the weather, comparing the weather against predispositions for skin 
problems like melanoma, and making suggestions for use of skin products such as 
sunblock (Sequencing.com 2018). This POC is of particular interest because it is 
essentially a smart app that is personalized to the user in an effort to create an easily 
actionable recommendation; and, as such, in many ways represents the future of 
genomics and the essence of why Sequencing.com was started.  
Sequencing.com was founded by Brandon Colby, an expert and entrepreneur in 
the field of personal genomics. Dr. Colby holds an MD from the Mount Sinai School of 
Medicine, an MBA from Stanford University's Graduate School of Business and a BA in 
Genetics with Honors from the University of Michigan. Prior to the launch of 
Sequencing.com, Dr. Colby practiced personalized preventive medicine in Los Angeles. 
Dr. Colby is the author of the popular book Outsmart Your Genes and has invented 
numerous patent-pending technologies that improve the analysis, interpretation and 
actionability of whole genome sequencing data (Sequencing.com n.d.).  
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Given Dr. Colby’s interest and vision, the growing market of genetic genealogy, 
and the recent FDA decision to allow 23andMe to sell genetic tests that advise 
consumers about their potential disease susceptibilities, Sequencing.com would like to 
pivot from their initial focus on academic researchers, healthcare professionals, 
bioinformaticians, and app developers to attract and retain consumers of the popular 
DTCG genealogical testing services. As a result of this, it is looking to understand better 
the beliefs, attitudes, intentions, and other motivating factors that may influence 
genealogical consumers to take health tests, as they represent potential customers of 
Sequencing.com. Furthermore, Dr. Colby would like to understand better what has or 
has not been working well for the consumers who have already adopted 
Sequencing.com, so that improvements to the product can be made. 
Sequencing.com became the client of this project as a result of an existing 
consultative engagement between myself and the company. Previously I have 
conducted a heuristics evaluation of the website, and the opportunity grew out of that 
previous engagement. Like that previous engagement, this project worked quite well for 
both parties.  Sequencing.com was very accommodating and supportive, and I have 
provided them with some early suggestions that they have implemented to their benefit 
already. One change that occurred throughout the process involved the recruiting.  The 
research initially planned to recruit 10 participants for the health group, but given 
complications in attracting willing participants, the health group ended with nine. 
Another change involved a minor shift away from the research question related with 
behavior change, as it became apparent that unpacking that was difficult as the 
participants did not seem that willing to discuss that on a deeper level. 
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The deliverables provided to the client included a current model of adoption of 
DTCG health testing; a proposed ideal target market, as well as product management 
and business strategy recommendations.  The model of adoption was mapped out 
across the five stages of adoption from the Diffusion of Innovations Theory and 
incorporated dimensions from the Technology Acceptance Model. It also incorporated 
influencing sociocultural variables uncovered in the course of the research. The model 
demonstrates how mediating factors across these theories affect the adoption process 
and lead to certain outcomes.  The ideal target market was based on important factors 
that influenced diffusion and adoption, and led to positive user experiences.  The 
business strategy recommendations involved short term objectives, and a long strategic 
intent. The short-term objectives were suggested in the spirit of creating a whole 
product concept that will serve the needs of different consumer groups as the product 
progresses along the adoption curve. The strategic intent recommended was to become 
the hub of consumers' genetic life. 
 
2.2 DTCG Genealogy Tests 
Direct-to-consumer genetic tests are marketed directly to consumers via 
television, print advertisements, or the Internet, and sold to them directly for use at 
home, typically without the involvement of a medical professional or an insurance 
company. The tests are often sold by companies that exist outside of the traditional 
healthcare sector. Upon purchase, a test kit is mailed to the consumer which allows 
them to collect a DNA sample. The sample can be collected many ways, but most often 
involves spitting saliva into a test tube or swabbing the inside of the cheek and then 
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placing the swab into a solution to transfer the cells. Either way, the sample is collected 
by the consumer in a sealable test tube which is typically placed in a biosafety bag that 
goes inside a pre-paid box and mailed back to a laboratory. At the lab, the DNA is 
sequenced, which usually takes between one month to a few months. When the results 
are ready, the company contacts the consumer, typically by email, and usually displays 
the results on a password protected website (US National Library of Medicine n.d.).  
The rise of the DTCG health testing model is a relatively new phenomenon, only 
becoming a possibility for consumers in the late 1990s and early 2000s as sequencing 
and analysis costs started to drop. At this time, the first tests that became available, and 
popular, were genealogy tests. This process of creating awareness and popularization 
started with surname research by Bryan Sykes, a molecular biologist at Oxford 
University. His study sought to understand whether genetics could be used to assist 
genealogical research. The study, which looked at only four markers on the male 
chromosome, proved useful (Sykes and Irven 2000).  
Following this, in March of 2000, Family Tree DNA (FTDNA) launched eleven 
marker Y-Chromosome STR tests and HVR1 mitochondrial DNA tests that expanded on 
the Sykes surname project (Wikipedia 2018). With this test, and FTDNA’s online 
surname database, genetic genealogy research moved out of academia and into the 
publicly available commercial space of capitalism. This was followed the same year by 
Oxford Ancestors, a spinout from Oxford University, based on the Sykes surname 
project (Oxford Ancestors n.d., International Society of Genetic Genealogy 2017). 
These two publicly available tests marked a turning point, and after their release the 
flood gates broke open. By 2003, the field of DNA testing for genealogical purposes was 
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deemed to have arrived by Jobling and Tyler-Smith in the Nature Reviews Genetics that 
year (International Society of Genetic Genealogy Wiki 2015). They made this claim 
based on the fact that many more consumers were starting to buy tests, and more tests 
were becoming available from other private companies, a trend which would only 
continue. 
By late 2007, there were many new private players in the industry such as the 
National Geographic’s Genographic Project, African Ancestry, DNAPrint Genomics, 
Sorenson Genomics, Genomac, and Relative Genetics, as well as FTDNA and Oxford 
Ancestors.  Together, these private DTCG companies had sequenced an estimated 
550,000 to 650,000 genomes for genealogy purposes, with bullish estimates ranging 
between 600,000 to 700,000 (Bettinger 2007). Since 2007, this trend has continued, 
supported by ever decreasing costs in the sequencing space, as well as other 
technology costs associated with storing and delivering the results. For example, the 
cost to sequence a whole human genome in 2008 was almost $10 million. In mid-2015, 
it was just above $4,000, and by late in 2015 it had fallen below $1,500. Today it is 
close $1,000 (National Institute of Human Genome Research 2016).  
Making these tests even more affordable is the fact that a whole genome 
sequence is typically not carried out for genealogical purposes.  In fact, a very small 
portion of the entire genome is often sequenced by one of the three common types of 
tests: mitochondrial, Y, and autosomal. Mitochondrial DNA (mtDNA) tests, trace a 
person's matrilineal or mother-line ancestry using the DNA in their mitochondria. Y-DNA 
tests, while more expansive than the mitochondrial tests, still only look at one 
chromosome, the Y chromosome, out of the 23 total human chromosomes. Autosomal 
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DNA tests look at any DNA that exists within the 22 non-sex chromosomes, as opposed 
to the sex chromosomes. Typically, these tests look at known single-nucleotide 
polymorphisms (SNP), which are changes to a single nucleotide in a DNA sequence. 
The number of SNPs reviewed differs by company, but is often in the range of 500,000 
to 750,000 SNPs. (International Society of Genetic Genealogy 2017). 
When taken together, the rapidly falling costs of sequencing, combined with the 
practice of carrying out only partial sequences, has led many more players into the 
market. In fact, by 2016 there were an estimated 74 companies providing DTCG tests 
for ancestry purposes (Phillips 2016). But despite there being an estimated 74 
companies, only a few seem to be leading the way today based on acquisitions, 
diversification, partnerships, and/or venture capital. AncestryDNA for example, which 
only started its DTCG testing service in 2012, has since acquired other ancestry 
companies including Relative Genetics, GeneTree, and Sorenson Molecular Genealogy 
Foundation. These acquisitions, paired with the existing market share Ancestry had in 
the genealogical family tree space, allowed them to sequence over one million 
customers in their first three years, and 12 million by the close of 2017 (MIT Technology 
Review 2018).  
Similarly, Gene by Gene, founded in 2000 as Family Tree DNA, later diversified 
to create the brands DNA Traits and DNA DTC for the purposes of offering other types 
of DTCG tests, such as a whole genome test.  They have also acquired other ancestry 
companies along the way, including DNA Heritage and DNA-Fingerprint, and have 
partnered with National Geographic to provide testing for National Geographic's global 
genetic survey, the Genographic Project (Petrone 2015).  
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23andMe, a latecomer to the DTCG space like AncestryDNA, is also worth noting 
for it epitomes the Silicon Valley model of DTCG.  Started in 2006 by Anne Wojcicki, an 
ex-investment banker looking to disrupt conventional business models of health care, 
23andMe raised $8.95 million in 2007 from a number of high-powered investors, 
including the biotechnology powerhouse, Genentech in South San Francisco and 
Google, whose co-founder Sergey Brin, was married to Wojcicki from 2007 to 2015. 
Using this capital, 23andMe was able to rapidly scale with less concern for breaking 
even in their early years.  In October 2009, two years after their first round of 
investment, 23andMe only had 30,000 active genomes in its database (Patch C 2009). 
But given their various rounds of funding, including their most recent raise of $250 
million announced in September 2017, their database grew to include 2,000,000 
genomes by October 2017, a change of 6566.66% over eight years (Hayden 2017). 
The competition that these acquisitions, diversification, partnerships, and/or 
venture capital unleashed, has created a race to the bottom when it comes to the cost 
of selling genealogical tests. Whereas in the early 2000s, DNA tests were many 
hundreds of dollars, today you will often find an autosomal kit priced around $100 or 
less when on sale. In fact, during the 2017 week of Black Friday sales and the end of 
year holiday sales, when the DTCG companies are fiercely competing for business, 
most autosomal kits were selling near the $70 price point. This, in turn, has led to many 
more consumers buying the kits, across all 74 DTCG companies, particularly the 
leading brands of AncestryDNA, 23andMe, Gene to Gene (FTDNA), and National 




2.3 DTCG Health Tests  
Riding the wave of decreasing costs and building on the success of DTCG 
consumer genealogical testing, companies started to emerge to offer health testing 
outside of the clinical setting.  The first wave of health tests that emerged primarily fell 
into the predictive category of DTCG health tests. At this time, there were three 
companies offering tests in that space (Williams-Jones 2003). Following this, in 2002 
susceptibility tests started to hit the market providing information on gene variations that 
may predispose an individual to develop common health conditions or have certain 
traits. Common examples included genetic variation in drug response, clotting 
disorders, fetal sex, hereditary hemochromatosis and nutrition (McBride, Wade and 
Kaphingst 2010). Sciona, an example of a DTCG company focused on nutrigenetic 
testing, analyzed consumers’ DNA to look for genes related to nutrient metabolism and 
provided personalized dietary recommendations (Hogarth and Saukko 2017). 
Building on the success of these earlier companies 2003 to 2007 saw an 
explosion in the market with a fourfold increase (14 to 53 tests) in the number of 
available DTC genetic tests (Goddard, et al. 2009). Within this new group of companies 
were Navigenics and 23andMe. Both were very well capitalized compared to their 
competitors. Both were also respectively well aligned to the leading DNA sequencing 
chip companies, Affymetrix and Illumina, who produced chips that were used to rapidly 
sequence portions of genomes. These chips were helping to fuel genome-wide 
association studies in which hundreds of thousands of genetic variants are examined in 
large numbers to detect gene-disease associations, which in turn was fueling the ever-
increasing number of susceptibility tests that could be offered to consumers. Given this 
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opportunity, Affymetrix and Illumina were also looking to move into this new DTCG 
space of commercial test to increase their market share.  
Likewise, the market collectively diversified away from only the traditional 
biomedical space, and by the fall of 2007 there were 27 distinct online DTC testing 
websites offering 53 unique health tests in the price range of $90 to $5400 (McBride, 
Wade and Kaphingst 2010). Building on the advancements and collaborations within the 
genetic industry, Navigenics and 23andMe also formed collaborative partnerships with 
Microsoft and Google respectively (Hogarth and Saukko 2017). Together, this alignment 
between sequencing chip manufacturers, well capitalized DTCG startups, and tech 
giants capable of storing vast amounts of data helped to set the stage for a new era of 
DTCG. 
Riding on the back of the confluence of forces that came together over the past 
few years to make health testing almost as approachable as genealogical testing, a 
second wave of companies such as 23andMe, Navigenics, and deCODEme began 
offering complex tests in late 2007 that cost in the range of $429–$1000. These tests, 
compared to some of the earlier tests which analyzed only a few hundred gene variants, 
were now analyzing thousands (McBride, Wade and Kaphingst 2010). Given this new 
opportunity, the testing companies began to expand their product offerings deeper into 
the wellness and medical market and started to advertise on social media actively.  This 
series of events, along with media coverage like Time Magazine naming the Retail DNA 
Test the 2008 Invention of the Year led to an increase in awareness of DTCG health 




The scrutiny started in 2006 when the U.S. Federal Trade Commission (FTC), 
Food and Drug Administration (FDA), and Centers for Disease Control and Prevention 
(CDC) published an FTC Fact for Consumers report titled At-Home Genetic Tests: A 
Healthy Dose of Skepticism May Be the Best Prescription. The fact sheet stated 
consumers should “be wary of claims about the benefits these products supposedly 
offer,” and “while these tests may provide some information your doctor needs or uses 
to make treatment decisions for a specific condition, they are not a substitute for a 
physician’s judgment and clinical experience” (Federal Trade Commission Bureau of 
Consumer Protection Division of Consumer and Business Education 2006, para. 10, 
para. 13). This was followed by the U.S. Government Accountability Office (U.S. GAO) 
study of four nutrigenetic testing companies. The study found that the test results 
predicted the consumers were at risk of various diseases, even though the tests 
themselves carried disclaimers stating they were not intended for diagnosis (United 
States Government Accountability Office 2006). 
By 2008, when the second wave of DTCG testing kits from 23andMe, deCODE 
and Navigenics were starting to gain market share, the FDA was debating whether or 
not they should start regulating a certain type of Laboratory Developed Test (LDT) 
known as In Vitro Diagnostic Evaluation and Safety (IVDMIA). The reason for debating 
the issue focused on concerns regarding analytic validity, the reliability of the actual 
genetic test and laboratory performance; clinical validity, whether the genetic variant 
corresponds to the condition or trait, and consumer comprehension (Curnutte 2017). 
The corollary to this FDA debate was whether or not the potential regulation of LTDs 
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should be extended to genetic tests. In the end, no decision was made, and DTCG 
companies continued operating relatively unencumbered.  
As prices declined further, advertising and media coverage continued to 
increase, resulting in growing market share. These developments led other critical 
players outside of the regulatory agencies to get involved in the debate. Leading 
scientists such as the National Institute of Health (NIH) soon-to-be chief Francis Collins, 
and Craig Venter, one of the driving forces of the Human Genome Project (HGP) to 
speak up. They were calling for more transparency, which led Congress to request that 
the U.S. GAO launch a second study (Genomic Law Report 2010). This study sought to 
detail the reliability of the tests and company privacy policies. The findings were 
discussed in a 2010 Congressional hearing that involved experts testifying that the 
DTCG company information was not sufficient for medical use and was instead only "for 
entertainment purposes" (Spector-Bagdady 2015, 569). 
Congress echoed the report findings and stated that the DTCG companies 
misled consumers and used deceptive marketing practices. The FDA then sent warning 
letters to 15 DTC firms to notify them that their tests were, in fact, medical devices, and 
therefore, under the jurisdiction of the FDA (Curnutte 2017). In the letter to 23andMe, 
the FDA stated “The 23andMe Personal Genome Service™ is a device under section 
201(h) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. 321(h) 
because it is intended for use in the diagnosis of disease or other conditions or in the 
cure, mitigation, treatment, or prevention of disease, or is intended to affect the 
structure or function of the body” thereby finally making it legally clear where the FDA 
stood on the matter (Food and Drug Administration 2010, para. 1).  
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Following this, some of the companies, led mainly by 23andMe, started working 
more closely with the FDA. However, in the case of 23andMe, which was the clear 
market leader for DTCG health testing at the time, this trend seemed to stagnate after 
they failed to deliver on a January 2013 promise that they would share more data with 
the FDA. In May of that year, 23andMe stopped communicating according to the FDA, 
despite the fact that 23andMe had recently launched a $5 million advertising campaign. 
This breakdown in communication led to the FDA sending a cease and desist letter on 
November 22, 2013, ordering 23andMe to stop marketing its product (Hayden 2017).  
In the letter, the FDA stated: "even after these many interactions with 23andMe, 
we still do not have any assurance that the firm has analytically or clinically validated 
the Personal Genome Service (PGS)" (Food and Drug Administration 2013, para. 6) 
The FDA statement was made based on 23andMe's "health reports on 254 diseases 
and conditions, including categories such as carrier status, health risks, and drug 
response, and specifically as a first step in prevention that enables users to take steps 
toward mitigating serious diseases" (Food and Drug Administration 2013, para.2 ). After 
this, 23andMe was able to operate still and provide trait and ancestry tests, but the 
medical tests that the FDA had classified under medical devices could no longer be 
sold.  
But determined to get back to selling their health tests, 23andMe, under the 
guidance of a legal team, began cooperating with regulators. Through the process, the 
regulatory environment that was to govern the DTCG industry going forward gradually 
came into focus for all parties, and controls were detailed by the FDA to make it more 
transparent what steps needed to be taken to provide adequate assurances of safety 
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and efficacy. DTCG companies wishing to sell over-the-counter (OTC) tests would need 
to give consumers information about the biological sample collection device itself, which 
must get FDA clearance and the details about the test's analytical performance. The 
FDA also wanted to see documentation on other instrumentation and software used in 
the testing process.  
With these new guidelines in hand, 23andMe began the process of obtaining 
approval for a DTCG health test, and at the end of 2014, asked the FDA to approve one 
such test. The test was for Bloom Syndrome and was intended to inform consumers if 
their children might inherit a genetic risk for the disease. 23andMe seemingly started 
with the Bloom Syndrome test because it is a carrier screening test, which implies the 
test informs consumers if they are carrying one or more copies of a gene, but does not 
necessarily mean that the disease will be inherited. Therefore, the tests results do not 
provide a disease diagnosis. This point was critical, as demonstrating the validity of 
identifying a single gene disease is much easier than a polygenic disease. As part of the 
approval process, the FDA also required 23andMe to address utility concerns, requiring 
them to test users for comprehension, requiring a score of 90% or greater for each 
comprehension concept (Curnutte, 2017). 23andMe complied, and with all of the 
requirements met by early 2015, the FDA approved the test in February 2015, making it 
the first FDA approved DTCG test in the United States available for sale to consumers.  
In their approval letter to 23andMe, the FDA stated “The FDA believes that in 
many circumstances it is not necessary for consumers to go through a licensed 
practitioner to have direct access to their personal genetic information. Today’s 
authorization and accompanying classification, along with FDA’s intent to exempt these 
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devices from FDA premarket review, supports innovation and will ultimately benefit 
consumers. These tests have the potential to provide people with information about 
possible mutations in their genes that could be passed on to their children,” and a result, 
a near fifteen-year period of uncertainty had seemed to come to an end (Reuters 2015, 
para. 6). 
Following this, 23andMe once again took the lead, and by April 2017, through 
cooperation with regulators, they were approved for another ten disease-related 
susceptibility tests, which they achieved by conducting "extensive validation studies for 
accuracy and user comprehension that met FDA standards" (23andME 2017, para. 5). 
As a result of this process, they have helped prepare the way for many other DTCG 
companies, and in the process helped to push the FDA to articulate the required 
controls. The question now is when, why and how will the majority of consumers adopt 





In this chapter, I look at existing literature from anthropology, sociology, 
communication, information science, and business management to help us understand 
why DTCG testing is adopted and how it spreads. I also document some of the larger 
social forces at play that relate to its adoption, and then discuss how the use of design 
anthropology represents an ideal theoretical and methodological toolkit for intentionally 
designing product and business strategies which are culturally aware and sensitive of all 
stakeholders.   
3.1 Design Anthropology 
Design anthropology is a form of applied anthropology that it is reflective, yet 
given its design orientation, also deliberately and openly prescriptive. Moreover, design 
anthropology is adept at solving modern complex problems given its ability to 
understand the problem by conducting applied research which is framed through the 
theory and scholarship of cultural anthropology, linguistic anthropology, and 
archaeology (Wasson 2016).  
Design anthropology grows out of the confluence of multiple disciplines which 
include design and anthropology but is by no means limited to them. This trend of 
blending disciplines seems to have arisen in its modern context with information 
technology in the early 1990s as a result of the new challenges it presented. At that 
time, design consulting firms like IDEO, Fitch, and frog were starting to bridge industrial 
design and engineering. Similarly, larger research labs like Xerox PARC, Microsoft 
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Research, and Bell Labs technologies had been bringing together communication 
designers, usability and human factors engineers with social scientists from 
anthropology, linguistics, and sociology. The goal was to "understand how people 
thought machines worked, to understand the interactions between people and 
technology, and the reciprocal impact of organizations, practices, and technologies on 
one another" (Clarke 2017, 57). 
Building on the foundations of these earlier movements, pioneering design firm 
E-Lab helped to bring design anthropology into its own right by fostering a model of 
collaboration between designers and anthropologists, thereby bringing together design 
and ethnographic practice (Wasson and Metcalf 2013). E-Lab is important because it 
fostered an equal partnership between research and design, with teams of roughly 
equal representation and influence, and ethnographic methods were the core of their 
research methods (Wasson 2000).  
This was important because before ethnography being used, cognitive 
psychology as the social science research model of choice (Norman 1988). The 
problem with this previous model was that it mostly accounted for what the user was 
thinking, and often failed to understand the larger institutional and cultural contexts that 
the use was embedded in (Robinson 1993). Furthermore, before the greater degree of 
equality between research (anthropology) and design that E-Lab promoted, 
anthropology was often just a complementary practice to design or usability testing, as 
opposed to "informing design to re-framing social, cultural and environmental relations 
in both design and anthropology" (Kjærsgaard 2011, 9). 
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Despite the advances E-Lab had achieved in realizing a higher degree of equality 
between the disciplines, not all design anthropology is created equal. Some theorists 
have argued that there are three models: dA, Da, and DA. 
∑ dA – The theoretical contribution is for anthropology rather than design. 
Design follows the lead of anthropology in terms of adopting theoretical 
understandings, or becoming the subject of anthropological study” (Gunn and 
Donovan 2012, 12). 
∑ Da – Fieldwork is in the service of design. Framing originates from problem 
orientated design approaches rather than engagement with peoples. 
Anthropology is put in service of design for example ethnographic studies are 
used for establishing design requirements“ (Gunn and Donovan 2012, 12). 
∑ DA – Disciplines of design and anthropology are engaged in a convergence 
of efforts each learning from the other each learning from the other” (Gunn 
and Donovan 2012, 12). 
These models are important to keep in mind because I do not seek to simply contribute 
to the theory of anthropology or improve the user experience of Sequencing.com. No, I 
seek to ensure that we are designing an ideal future state of DTCG, because whether 
we like it or not, with every object, technology, or system we create, we are designing 
cultures of the future (Balsamo 2011). 
Likewise, this thesis aimed to produce actionable product management insights 
that Sequencing.com could use to achieve competitive advantage, but, and this is 
critical, it must not be done at the expense of consumers. An innovation as disruptive 
and personal as genomics needs to serve consumers because it, possibly even more 
than other designed artifacts, will define what it means to be a human (Tunstall 2017).   
To produce the actionable insights, let us first look back at how ideas and 
innovations spread. From there, we will move on to factors that influence adoption, and 
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finally we will look at some ethical concerns that we need to design for if we are to 
produce DTCG that positively influence what it means to be human. 
 
3.2 Diffusionism and the Spread of Cultural Traits 
Given anthropology’s focus on culture, there is a long-standing tradition of trying 
to understand the origins of cultures and how they spread (Univerisity of Alabama 
Department of Anthropology n.d.). The collective body of this work falls under the broad 
theories of diffusionism. Diffusion research gained its foothold in a time in which the 
theory of evolution, colonialism, and industrialism where all on the rise in the middle of 
the nineteenth century.  
At this time, European and American anthropologists were seeking to understand 
how humans progressed in development from a primitive culture, to an advanced 
culture, such as those found in Europe. Of course, today, this perspective is widely 
understood to be Eurocentric and inaccurate, but at the time, anthropologists were still 
trying to understand if human culture evolved similarly as biological evolution, or 
whether culture spread in a diffusion process from innovation centers (Hugill 1996).  
One such model for the latter perspective came from the German diffusionist 
school known as the Kulturkreise (culture circles). The Kulturkreise school, led by Fritz 
Graebner, sought to explain the spread of culture as a process of by which traits radiate 
out from one or more central seed cultures (Univerisity of Alabama Department of 
Anthropology n.d., para. 1, para. 2. para. 3). He believed that cultural traits were 
borrowed through processes such as marriage, trade, war, and communication. He felt 
that once these new traits were encountered, they were adopted by the new culture, 
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and applied to the new context, thus making them at once similar, yet culturally distinct 
(Harris 1968).  
Also working around this time, Gabriel Tarde, a French sociologist, theorized that 
significant sociocultural change requires the diffusion of innovations, and believed these 
innovations, which were infrequent moments of genius, required the support of key 
social members to help the ideas spread. Support came in the form of belief and 
adoption of the innovation. The diffusion process involved key social members 
communicating their support, which would in turn be mirrored others people who imitate 
the beliefs (Kinnunen 1996). 
 
3.3 Diffusion of Innovations 
Building on the synergy between these theories, numerous models have been 
created to explain diffusion in a modern global context. One of those, aptly named the 
Diffusion of Innovations (DOI) theory by Everett Rogers, attempts to explain why, how, 
and the pace at which new ideas and technology spread. In his 1962 book titled the 
Diffusion of Innovations, and the four subsequent additions which included substantial 
cross-cultural data from around the world, Rogers argued that diffusion is the process 
by which an innovation is communicated between people within a social system. Since 
the initial publication of his book, this particular type of diffusion research has been 
applied by scholars across the globe, in diverse disciplines such marketing, public 
health, economics, sociology, communication, geography, management, education, 
public administration, political science, and information systems, to understand the 
adoption and diffusion of ideas. 
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To better understand factors influencing adoption, Rogers focused on five key 
elements of the process: the adopters, the innovation, communication channels, time, 
and the social system. Adopters are the individuals or groups such as businesses and 
governments which make decisions to adopt something. The innovation is any new 
idea, practice, or object that could be adopted. Communication channels are the means 
by which new information is transferred. Time is the period in which the adoption 
occurs. The social system is the interconnected web of relationships that influence an 
adopter’s decision, be it mass media or direct social relationships. (Rogers 2003). 
For Rogers, diffusion transpires as a result of a five-step decision-making 
process that occurs through communication channels over time within the social 
system.  The five steps are knowledge, persuasion, decision, implementation, and 
confirmation. The knowledge step involves individuals first being exposed to the 
innovation but not yet interested in it. In the persuasion step, an individual becomes 
interested and seeks out more information. This is followed by the decision stage where 
an individual either decides to adopt the innovation or not. In the implementation step, 
an individual makes use of the innovation and makes a subjective decision about its 
usefulness. Finally, in the confirmation step, an individual will decide whether or not to 
keep using the innovation, which is based both on their own beliefs, as well as social 




Figure 1: Five Stages in the Decision Innovation Process (Wikipedia 2009) 
 
Building on the five-step decision-making process individuals use in deciding to 
adopt an innovation or not, Rogers also classifies adopters into five groups: innovators, 
early adopters, early majority, late majority, and laggards. Innovators are the first group 
to adopt, and they are more apt to take risks, have greater financial resources, and 
often the highest social status. They are followed by early adopters who are similar to 
innovators in that they usually have more financial resources and higher social status. 
However, they are slightly more risk-averse than innovators and make choices about 
adoption based on that perceived risk. They also have the highest degree of opinion 
leadership out of the five groups. The early majority have above average social status, 
but take considerably longer to adopt the innovation, and have less opinion leadership 
than the early adopters. The late majority typically adopt an innovation after the mean of 
the population, based on a high degree of skepticism, and/or lack of financial resources. 
They also often have lower social status and little opinion leadership. Finally, the 
laggards are the last group to adopt an innovation. They have minimal social status and 
opinion leadership. They often also lack financial resources and social connections and 
may be considered very traditional in their worldview (Rogers 2003). 
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To better understand the time component of adoption, the DOI plots the adoption 
groups through time along the adoption curve, which mirrors the bell curve, to indicate 
when those groups adopt a new idea or technology and in what percentage. As time 
advances and the more groups adopt, a point of saturation is achieved in the market. 
This process of saturation maps to an S Curve which is overlaid on the adoption curve. 
The relationship between data points demonstrates that as the late majority starts to 
adopt the technology, the rate of adoption drastically speeds up, reaching a point that 
Rogers calls the critical mass. At this point, the adoption has become widespread, and 
is almost self-replicating, with little to no need from those with greater social status to 
spread the innovation, as it has become a social norm (Rogers 2003). 
 
Figure 2: DOI Adoption and S Curves (Wikipedia 2012) 
 
The power in the Rogers framework of diffusion research is that it has been 
systematized, which makes it easier to understand and study the broad constructs such 
as the elements, process, and the time component. However, DOI can benefit from the 
addition of other theories to help develop a deeper understanding of various dimensions 
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such as the innovation, communication channels, the social system, and even the 
adopters.  
 
3.4 Technology Acceptance Model 
The Technology Acceptance Model (TAM), which historically was applied to 
information systems in a business context, builds on the Theory of Reasoned Action by 
implementing factors for measuring attitude based on technology acceptance criteria.  
 
Figure 3: The Technology Acceptance Model (Wikipedia 2013) 
 
The criteria introduced by TAM includes perceived usefulness and ease of use. 
In the landmark publication on the topic, Fred D. Davis defined perceived usefulness as 
"the degree to which a person believes that using a particular system would enhance 
his or her job performance" where useful is defined as "capable of being used 
advantageously" (Davis 1989, 320). He went on to define perceived ease of use as "the 
degree to which a person believes that using a particular system would be free of effort" 
where ease is defined as "freedom from difficulty or great effort” (Davis 1989, 320). The 
research found that both perceived usefulness and ease of use were significantly 
correlated with self-reported indicants of system use (Davis 1989). 
Furthermore, Davis found that “usefulness was significantly more strongly linked 
to usage than was ease of use” (Davis 1989, 333). Elaborating on this point, he stated 
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“although difficulty of use can discourage adoption of an otherwise useful system, no 
amount of ease of use can compensate for a system that does not perform a useful 
function… thus, a major conclusion of this study is that perceived usefulness is a strong 
correlate of user acceptance and should not be ignored by those attempting to design or 
implement successful systems” (Davis 1989, 334). 
Thus, TAM can help us better understand many of the human decisions making 
factors that contribute to adoption, thereby enhancing the power of DOI.  To build on 
these theories further, we still need to gain a deeper understanding of innovation, 
communication channels, and the social system. To begin, we will start with the 
innovation, but with a specific type of innovation that DTCG health testing falls into. 
 
3.5 Disruptive Innovation and Crossing the Chasm 
Disruptive innovation is a specific type of innovation that creates new markets 
and upends existing markets, and in the process, displaces established market leaders 
and products.  The phrase disruptive technology was coined by Clayton M. Christensen 
in his 1995 article Disruptive Technologies: Catching the Wave, and later expanded on 
in his 1997 book The Innovators’ Dilemma. Christensen theorized that disruptive 
technologies would initially lag behind established ones since they satisfy only the 
needs of a small group, such as the innovators or early adopters, but over time as the 
technology matures it starts to satisfy the broader needs of the mainstream market 
compromised of the early and late majority (Christensen 1997). 
Disruptive innovations are divided into two groups: product discontinuities and 
process discontinuities, where the discontinuities are either competence-destroying or 
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competence-enhancing. Competence-destroying discontinuities require new skills, 
abilities, and knowledge in the process of delivering a new product class. Competence-
enhancing discontinuities are achieved by drastic improvements to existing products 
and thus don't require new skills, abilities, and knowledge (Thomond and Lettice 2002). 
When disruptive innovations are competence-destroying, such as DTCG health testing, 
they involve dramatic leaps in customer knowledge and use. As a result of this, there is 
a critical hurdle that needs to be overcome to achieve critical mass adoption by the 
early majority and late majority (Veryzer, Jr. 1998).  
This hurdle, referred to as a chasm by Geoffrey Moore in his book Crossing the 
Chasm, represents the challenge of getting from early adopters to the early majority. To 
highlight this challenge, Moore updated the typical adoption curve from Rogers' diffusion 
research which was then applied to the Technology Adoption Lifecycle (TALC). His 
updates included tweaks to the adopter category names to convey particular influencing 
factors about them and placed a visual gap, the chasm, in between the early adopters 





Figure 4: Crossing the Chasm Adoption Curve (Dwayne Nesmith 2017) 
 
For Moore, to get from early acceptance to the start of the critical mass, 
companies need to make intentionally strategic choices about positioning the product, 
building a marketing strategy, choosing the most appropriate distribution channel, 
establishing pricing, creating a whole product concept, and choosing a target market. All 
of these are critical considerations; however, for this thesis, we will focus on the last 
two. When choosing a target market for a disruptive innovation, companies cannot be 
all things to all people when trying to cross the chasm. They must focus on a specific 
segment within the potential adopter early majority pragmatist category. This segment 
should have a particular need that the disruptive innovation can satisfy because it 
makes the group more receptive, and easier to market to, thus making it possible to 




To scale this model, Moore put forth the idea of the bowling alley in one of his 
later books, Inside the Tornado: Strategies for Developing, Leveraging, and Surviving 
Hypergrowth Markets. The bowling alley advises companies to line up all of the needs 
of specific pragmatist groups in such a way whereby you sequentially add more 
features, which satisfies the needs of more groups of pragmatists. As this happens, the 
disruptive innovation increasingly becomes more of a whole product concept that serves 
the entirety of the needs of consumers. When this happens, and more user segments 
within the pragmatist's adopter category adopt, a point is eventually reached which 
Moore calls the tornado. In this period, adoption of the innovation moves into the 
hypergrowth phase along the S Curve described in DOI, and the late majority begin to 
adopt the innovation in increasingly greater numbers with less need for social influence 
from those with higher social status, and eventually, the innovation becomes a social 
norm (Moore 2004). 
In light of Christensen’s theory of disruptive innovation and Moore’s Crossing the 
Chasm model, we now have a better understanding of the challenges of obtaining 
critical mass adoption of disruptive technologies like DTCG health testing. But, we still 
need to explore how communication channels and the social system aspects of DOI 
effect adoption. 
 
3.6 Communication Channels and Social Influence 
In the early days of diffusion and acculturation research, it was stated that direct 
contact was needed for the spread of innovations. While that holds true, direct contact is 
by no means the only mode of transmission today, and, it may be argued that it is now 
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the minority mode in a world filled with electronic communication. Electronic 
communication takes the form of TV and the internet at large but also includes specific 
internet-based technologies such as mobile phones and social networks which in some 
cases such as Facebook, have grown larger than many countries. In this new world of 
electronic communication ideas and innovations can spread quicker and to more people 
than could have been imagined in the days of the early diffusion and acculturation 
research, or even Rogers' research for that matter. Likewise, electronic communication 
has become the dominant communication channel affecting adoption and diffusion. 
But, when Rogers first published the Diffusion of Innovations, TV was still in the 
process of becoming the norm, cable TV and the internet had not yet been invented, the 
need for around the clock media content was not yet a business problem needing to be 
solved, and mass consumption within echo chambers on mobile phones wasn’t even a 
dream outside of science fiction. Likewise, the DOI incorporated the two-step flow of 
communication model which comes from Paul Lazarsfeld and Elihu Katz (Katz and 
Lazarsfeld 1955). In that model, it was stated that most people form opinions from social 
influencers who are themselves influenced by mass media. These social influencers 
were assumed to have greater access to media, and thus acted as a translator of media 
content for the masses. This two-step model was in contrast to a one-step model which 
theorizes that people are directly influenced by mass media, which was assumed to not 
be relevant given the inequalities in access to mass media at the time. Today though, 
communication researchers theorize that both of these models, as well as other more 
complex forms of communication playout across the various forms of electronic 
communication channels, especially social networks.  
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In fact, in one recent study of political communication on Twitter, four types of 
nodes: "Voice," "Media," "Amplifier," and "Participants" were identified (Hilbert, Vasquez 
and Halpern 2016, 7). Voices were the individual or organizational social network 
accounts. Media was self-identified media outlets. Amplifiers were social influencers, 
that did not belong to the previous two groups, but had public status which could stem 
from formal authority (politicians, non-specialized organizations or organization with a 
focus besides the conflict or media, general activists, union leaders, etc.), or public 
visibility (actors, artists, musicians, celebrities, bloggers, athletes, etc.) Participants 
consisted of all other people. In this study, it was found that "the average Voice is the 
most intense communicator (highest centrality), followed by Media outlets and only then 
Amplifiers" but "Amplifiers are more omnipresent and maintain the strongest 
communication link with Participants." This finding led the authors to conclude that both 
one and two-step processes were in use (Hilbert, Vasquez and Halpern 2016, 17).  
So, if this is true, how does it relate to DTCG and social influence? The answer is 
that social influence can occur through contact with someone such as a family member, 
a friend, a person of perceived authority, businesses, or mass media; and this social 
influence plays out in person or electronically.  To explore this, let us first look at some 
previous research on the adoption of genetic testing that made use of theories 
discussed in this chapter. We will use these studies to demonstrate how the decision-
making process has occurred in the early adoption of genetic testing and to point out 
how social influence and norms have affected the decision to adopt genetic testing in 
real world settings.  
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One study which looked at early adoption of genetic testing made use of the DOI 
theory to understand the adoption of genetic testing among women who were 
participating in genetic counseling related to the BRCA1/2 gene variant. In this study it 
was found that “the uptake of BRCA1/2 testing among women undergoing genetic 
counseling was associated with innovative characteristics of the participant and the 
perceived compatibility of the test with existing values and needs” (Armstrong, et al. 
2003, 92). Furthermore “most participants had heard of BRCA1/2 testing from a source 
other than their physician and had sought testing because of a personal or family 
member’s cancer diagnosis” (Armstrong, et al. 2003, 92). 
Another study that looked at early adoption of genetic testing used Ajzen’s 
Theory of Planned Behavior (1991) to understand why an individual may take a genetic 
test for Alzheimer's Disease (AD) (Ajzen 1991). It was found that the subjective norm 
was the strongest predictor of adoption for individuals who were told that positive results 
on the test correlated to a 90% chance of developing AD. This was in contrast to 
another group who was told that positive results on the test correlated to a 50% chance 
of developing AD. For the latter group, a positive belief, such as having the ability to 
deal effectively with the results, was the strongest predictor. The authors summarized 
their research by stating “our findings highlight the influential role beliefs about genetic 
testing and normative beliefs in decision-making” (Frost, Myers and Newman 2001, 
108).  
With these studies in mind, now let us look at the social system component of 
DOI by bridging the previous findings into a discussion on some of the sociocultural 
36 
 
forces that contribute to shaping the sociotechnical normative beliefs of our society in 
the United States. 
 
3.7 Science and Business as Social Norms 
It can be argued that in the United States, trust in science is a normative belief, 
with the majority of the population supporting science as an institution of our culture. In 
fact, in the recently released National Science Board Science and Engineering 
Indicators for 2018, it was stated that “Americans have high confidence in the scientific 
community. Amid a long decline in public confidence in several U.S. institutions, many 
Americans continue to have a “great deal of confidence” in the scientific community 
(National Science Foundation 2018, 20). This perception has endured over 3 decades 
and is second only to confidence in the military (National Science Foundation 2018).  
 
Figure 5: Public confidence in institutional leaders, by selected institution: 1986–2016 
(National Science Foundation 2018) 
 
Building on this, it was found that the public have consistently maintained a very 
positive view of science as a body of knowledge that benefits society.  It was found that 
“Americans believe that science creates more opportunities for the next generation, that 
37 
 
its benefits outweigh risks, and that the federal government should provide funds for 
scientific research”  (National Science Foundation 2018, 20). 
 
Figure 6: Americans' views of science: Selected years, 1985–2016 
(National Science Foundation 2018) 
 
Furthermore, when the participants were asked about how they feel about 
scientists, it was found that “Americans have a positive view of scientists. The clear 
majority of respondents agree or strongly agree that scientists work for the good of 
humanity, help to solve problems, and want to make life better for the average person. 
These views have remained mostly unchanged since 2001” (National Science 
Foundation 2018, 20). But if above average trust and belief are placed in science as a 
body of knowledge and as a social institution, as well in the social influencer scientists, 
then we must ask, how did this social norm come to be, and what historical social forces 




Figure 7: Americans' views about scientists: 2001, 2012, and 2016 
(National Science Foundation 2018) 
  
The United States is thoroughly rooted in the Protestant work ethic, which 
according to Max Weber gave rise to the process of rationalization which embodied the 
belief that "one can, in principle, master all things by calculation" (Weber 1946, 139) 
This in turn led the rise of the scientific revolution, capitalism, and industrialism which 
created the foundation for our modern technoscientific economy.  
In this economy, technoscientific products that are sold by corporations exert a 
great deal of control on our lives from the way we travel, to how we communicate, to 
how we manage our health. Likewise, scientists and the studies they produce hold a 
great deal of social status. This is observable simply by looking at nearly any mass 
media source, be it in print or electronic. In these sources, you will typically find a 
science or health section, which is stocked full daily with summarized briefs of the latest 
research, and even if you don't go search for those headlines, don't worry, because they 
often float to the front page. But why is this?  
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Some theorists have argued that scientists, and corporations, often align and 
disseminate their research and public relations with the media via a phenomenon 
known as media orientation (Weingart 1998).  This was true of the scientists involved in 
the Human Genome Project (HGP), as well as the DTCG corporations today. Examples 
of the effects of this process are seen in a headline discussed earlier, where Time 
Magazine named The Retail DNA Test as its 2008 Invention of the Year, or more 
recently when Fortune called attention to 23andMe Raises Another $250 Million—and 
Wants to Use Your Genetic Data to Make Drugs (Fortune 2017).  
The reason this is important is that while this process can be useful for the 
spread of ideas, this orientation, and the outcome of this process, is not inherently 
neutral. In fact, in a previous study, which conducted a metaphor and discourse analysis 
of media that related to the HGP, it was found that the metaphors and hyperboles used 
attempted to steer the discourse towards public euphoria (Nerlich 2002). This is a 
concern because media can influence social change like discussed in the Hilbert et.al. 
study.  
Further amplifying the effectiveness of medialization is advertising. Today, the 
most common advertising strategy used by companies in health is called Direct-To-
Consumer (DTC) advertising, which is a term that has been used to describe the 
advertising tactics of pharmaceutical companies since the 1980s. DTC advertising 
makes use popular media such television, radio, magazines, newspapers, billboards, 
direct mailings, and more recently the internet, to target consumers directly (Ventola 
2011). The power of DTC advertising, especially in a world of contextual based 
advertising on platforms like Facebook, is that it allows corporations selling 
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technoscientific innovations to get out in front of consumers who match a very specific 
profile they wish to target and make promises to address their needs. 
 
3.8 Promissory Discourse and Future-Oriented Knowledge 
The promissory discourse used to attract consumers is based on “future-oriented 
imaginations of wellbeing, disease prevention and personal empowerment” (Arribas-
Ayllon M 2011, 53). The concern is that by invoking language that promises the 
consumer that their future state can be better than their current state, the DTCG 
companies are playing on the consumers’ own personal vulnerabilities, which in turn 
leads them to trust the testing process. This subjective appeal to emotion helps to 
sidestep the need for deceptive marketing practices based on promises related to 
disease diagnosis, prevention, or treatment, and instead supports the DTCG companies 
in attracting consumers through broad claims that can be made without regard for the 
governmental regulatory concerns. 
In a study of 46 DTCG websites, it was found that the appeals most often came 
in the form of a statement or testimonial that lays claim to positive feelings that a 
consumer will have after taking a test based on knowledge gained (Saukko 2013). 
Similarly, though occurring less frequently, the appeal may also seek to highlight the 
negative emotions, such as fear or regret, that may exist for a consumer who has not 
yet taken a test, and thus lacks the knowledge they could have in the future if they were 
to take the test. The most popular positive emotional appeals were found to be warmth 
and empowerment, occurring in 60.9% of the websites. The second most popular 
positive appeal, which was found in 34.8% of the websites, was assurance. These 
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appeals were followed by relief and happiness/joy, being found in 26.1% and 21.7% of 
the websites respectively. Fear was the most common negative emotional appeal used, 
occurring on 26.1% of the websites. This was followed by regret on 10.9% of the 
websites. It was also noted that the websites often make use of “healthy-looking, smiling 
people in a warm family setting, implying that genetic testing could bring about such 
desirable outcomes” (Liu and Pearson 2008, 141). Numerous other studies have also 
come to very similar conclusions, and have called attention to the fact that the language 
of these websites seems to resonate with consumers, given the discourse echoes the 
current beliefs in health that emphasize personal choice and responsibility for one’s own 
health (Saukko, 2013).  
 
3.9 Biosociality 
In 1996 Paul Rabinow coined the term “biosociality” to call attention to the 
implications of the Human Genome Project (HGP) (Rabinow 1996). In his writing, he 
described how social identity based on biological conditions could not only alter 
people’s personal identity, but also mediate their social relationships (Rabinow, 1996). 
While this term may appear self-evident based on the fact that humans are biosocial 
beings: biological animals and social animals, Rabinow was articulating a cultural trend 
in which the biological, and specifically the genetic, was being elevated in importance. 
Since then, and with the rise of DTCG, the concept of genetic-based biosociality has 
proven to be a point of interest for consumers in the US. A quick search on YouTube for 
Ancestry or 23andMe results produces many thousands of DTCG “results videos” in 
which the creators call attention to their new found understandings of their genetically 
42 
 
constructed ethnic identities. Similarly, the forums of Ancestry, 23andMe, and GEDCOM 
are active with conversations related to ethnicity and medical conditions.   
Advocates state that biosociality is helping individuals to better understand their 
identity and achieve a state of autonomy or control over their own health, and cite how 
virtual communities are emerging around rare genetic conditions, thereby allowing like 
individuals to connect with one another in ways previously not possible (Novas, 2006). 
Critics however fear the worst. Many call attention to concerns regarding our not too-
distant past with eugenics and the need to protect against direct discrimination along 
the lines of isms such as racism, sexism, classism, ableism, anti-Semitism, ageism and 
heterosexism, all of which are valid concerns (Allen 1999). Others have expressed the 
need to be aware of indirect causes that allow some of these isms to perpetuate, such 
as the structural violence which impacts access and outcomes to biomedical 
technologies and care, for they only reinforce the unequal relationships among 
individuals and between societal institutions such as government (Rahaman 2011).  
Furthermore, and possibly the greatest concern of all, is that in an effort to be 
ever more rational and controlled, the bureaucratic system governing biomedicine may 
institute and require a new form of citizenship, that of the genetic citizen, and in the 
process reinforce even greater social control over individuals in favor of the bureaucratic 
jurisdiction of biomedicine, and increasingly to the benefit of the private corporations 
that profit from the sale of biomedical technologies (Heath, Rapp, and Taussig, 2007). 
 
3.10 Biocapital 
Medicalization is a paradigm of western biomedicine that "assumes that all 
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human dysfunction might eventually be traced to such specific causal mechanisms 
within the organism," and it "presupposes a clear mind/body distinction where ultimately 
the causal agent of illness would be located in the human body" (Turner 1987, 10). As a 
result of medicalization, health has increasingly become a commodity for purchase and 
consumption with the goal of addressing all known health issues (Maturo, 2012). In the 
past few decades, this trend has expanded to incorporate a new form of 
commodification, one that merges capitalism and biotechnology. This commodification 
seeks to capitalize upon research in molecular biology through the appropriation of 
living nature—literally capitalizing life (Yoxen, 1981). This form of capitalism which is 
called biocapitalism makes use of the living and biological elements thereof (Helmreich, 
2008). It has applied to some existing industries like reproductive technology and will 
increasingly apply to fledging industries like stem cell research, but it also quite 
appropriately applies to genomics and all of the other omic sciences in the present 
(Helmreich, 2008).  
Biocapital will become the new form of capital which expands on Bourdieu’s 
forms of capital, and with it new opportunities and threats to equality as governments, 
corporations, and individuals negotiate for control of the data, and what can be done 
with it. If the individual, there is an impressive opportunity for empowerment. Their data 
could be exchanged to help push science forward in the spirit of rationalization, while 
earning money in the spirit of capitalism. If designed correctly, it could be a relatively fair 
trade that pays dividends on future value created for businesses or governments. 
Correspondingly business, like 23andMe and the other DTCG companies who have the 
skills and technologies to create the markets which support the two-sided business 
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models of biobanking can continue to earn substantial revenue, and if they wanted to, 
they could share the wealth generated via the biocapital they are collecting with the 





This chapter details the process of the research, including the research 
questions, research methods, project timeline, IRB review process, informed consent 
process, sampling design, recruitment process, semi-structured interview and 
observations outcomes, coding structure, and demographics. 
4.1 Research Questions 
Research questions were developed to guide the research and project design. 
The questions were crafted with the goal of addressing the immediate need of 
Sequencing.com and to begin to understand the broader landscape of DTCG. The 
research questions were: 
∑ What beliefs, values, lifestyle, priorities, needs and wants contribute to an
interest in consumer genomics?
∑ What are the motivations for consumers to make use of consumer genomics?
∑ What gaps in understanding genomics must be overcome before consumers
can make use of genomics?
∑ How does the genomic data need to be transformed and presented to create
educational opportunities and meaningful insights that consumers can apply
to improve health outcomes?
∑ Are consumers changing any health behaviors as a result of the test results
they receive, and why?
∑ How do consumers feel about sharing and owning their data?
∑ What ethical and privacy concerns do consumers have?
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4.2 Research Methods 
An ethnography of DTCG was conducted. Ethnography was selected for its 
ability to be both inductive and deductive, thereby supporting generative and evaluative 
research. This opportunity was desired since the research sought to broadly explore 
DTCG consumers, but also to produce some actionable insights that Sequencing.com 
could use to guide their product management strategy.  
Ethnography is also valued for its ability to be contextual and reflexive, in that it 
situates the findings in the collective circumstances where they were uncovered, and is 
self-aware of the effect the researcher has on the research design and process (Boyle, 
1994). Furthermore, it allows for the incorporation of a range of methods, which may 
include qualitative and quantitative.  
This study employed qualitative methods to collect data. The reason for this is 
that the study was mainly interested in discovery given the disruptive nature of DTCG 
testing. Discovery research was deemed fitting for this project because “the goal of 
discovery research is to uncover and understand the cultural system that frames human 
action to provide a direction for creating new products and services” (Squires 2002, 
107). To do this, researchers “collect and analyze a combination of verbal, 
observational, and contextual information to identify what people say and do in their 
natural environment” (Squires 2002, 107).  
Likewise, this research made use of semi-structured interviews and observations. 
Semi-structured interviews, or in-depth interviews, are an open-ended interview that 
follows a script to cover all essential topics but also leaves room for variation to uncover 
unexpected insights. (Bernard, 2006). Participant observation was also used to gain a 
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sense of what Sequencing.com users think about DTCG health testing in relation to the 
website. This was done as a way of situating their knowledge in the context of use. 
 
4.3 Project Timeline 
The following timeline was used to guide the research process  
 
4.4 Sampling Design and Recruitment 
The focus of the study involves two groups of consumers who were defined as 1) 
individuals who had previously used genealogical genomics products but not health 
products like Sequencing.com, and 2) individuals who had used Sequencing.com. The 
groups were selected to compare and contrast the beliefs, attitudes, intentions, and 
other motivating factors that influenced the groups to take the respective tests. Each 
group was intended to include 10 participants, for a total of 20 research participants. 
However, only nine Sequencing.com health participants were recruited. All participants 
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were required to be over the age of 18. The study sought to find a diverse group of 
participants that varied in age, gender, race/ethnicity, and socioeconomic status to 
achieve a sample that approximates the public of the United States. The participants 
were recruited in two ways based on the need to get both genealogy participants and 
Sequencing.com participants.  
Across both groups, participants were majority millennials (57.8%), female 
(57.9%), and never married (57.9%). All participants had taken some college courses, 
with the largest group having an undergraduate degree (36.8%), followed by 
participants who had taken some college courses but not earned a degree (31.6%).  
Overwhelmingly, the majority of participants did not study (78.9%) or work (89.5%) in 
science, and the majority were employed full time (52.6%). The majority were also 
middle class based on family size an annual income between 66 percent and 200 
percent of the median U.S. household income, according to the Pew Research Center 
(Pew Research Center 2016). The majority of participants also identified their ethnicity 
as white, of European descent (57.9%), and live in urban (78.9%) environments. What 
follows, is a breakdown of demographics by group, to compare and contrast the two. 
The genealogy group was recruited via userinterviews.com for a half hour phone 
interview. This process involved the researcher creating a project on 
userinterviews.com. The project creation required the researcher to detail the title, study 
type, description, compensation, communication modality, computer requirements (if 
required), phone requirements (if required), and browser requirements (if required). The 
researcher also had to select between consumers or professionals as the target 
audience. Once the research project was posted and accessible on the 
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userinterviews.com website, potential participants were able to review the project details 
and express interest in the research project, assuming they had a userinterviews.com 
account. If they expressed interest, they were required to fill out a screener survey 
which was created by the researcher and posted as part of the project creation process.  
The screener survey sought to advise them on the informed consent process 
which they would have to engage in if selected and to gauge more information about 
their past experiences with genetic genealogy as well as demographics. The results of 
the screener survey were recorded in the userinterviews.com control panel which only 
the researcher had access to. After reviewing the results, the researcher invited ten 
potential participants, who then had one more opportunity to accept or deny the invite. If 
the participant accepted the invite, they then selected a time on the researcher schedule 
based on availability that was also detailed in the project creation process. Once a 
potential participant accepted the researcher was then able to communicate with them 
directly based on the messaging platform that is built into the userinterviews.com control 
panel.  Participants who completed the research interview for the genealogy group 
received a $30 Amazon electronic gift card which was sent directly via 
userinterviews.com. This was processed as soon as the interview was completed. 
The genealogy group had 134 potential participants complete the screener 
survey.  Ten participants were initially contacted and invited to participate in the 
research. Of those 10, three participants canceled before the start of the interview, and 
one did not show, and thus the interview was canceled after a period of time by the 
researcher. Four subsequent participants were contacted, all of whom participated. 
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The Sequencing.com health group was recruited for a one to one-and-a-half-hour 
interview and observation session by pulling a list of users from the Sequencing.com 
database that met certain criteria. The criteria defined sought users who self-identified 
as consumer users during the sign-up process, who had uploaded at least one DNA 
data file, and used at least one application to analyze at least one DNA data file in the 
last year. The data also contained information on what service initially produced the 
DNA data file, such as AncestryDNA, 23andMe, MyHeritage, Genes for Good, and 
others. This list of users was used to identify potential participants.  Those potential 
participants were then emailed via Sequencing.com’s branded MailChimp account and 
asked to participate in user research. The email included a link to a screener survey that 
the research created in SurveyMonkey. If the potential participants wished to express 
interesting in being part of the study, they were required to fill out the screener survey.  
The screener survey sought to advise them on the informed consent process 
which they would have to engage in if selected and to gauge more information about 
their past experiences with Sequencing.com as well as demographics. The researcher 
then reviewed the screener survey results within the SurveyMonkey control panel and 
then emailed potential participants directly by email using a sequencing.com email 
address to set up the research sessions. Participants who completed the research 
interview and observation for the Sequencing.com health group received four $25 
coupons to use on Sequencing.com. These coupons could be used to purchase apps 
that are used to analyze the user's DNA data files. These coupon codes were 
processed within two weeks. 
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A small subset of Sequencing.com customers were selected as potential 
participants. The subset was made up of 559 potential participants. The 559 potential 
participants were grouped by the number of times (1-5, 6-10, and 11+) they had used 
Sequening.com to analyze a DNA file. Of the 559, 530 were invited to participate in the 
research. They were all emailed three times over a three-week period via 
Sequencing.com's e-newsletter service, MailChimp.  The MailChimp email contained 
the link to the screener survey. 35 potential participants filled out the screener survey. 
However, 8 were disqualified based on their answers. All of the remaining 27 potential 
participants were emailed by the researcher directly using a Sequencing.com email 
address. Of the 27 participants, two declined, and twelve never replied or confirmed a 
time to participate. The remaining 13 were scheduled for interviews and observation. 
However, four of them did not show. 
 
4.5 Demographics  
Demographic data was collected via written screener survey instrument for both 
groups. The screener survey collected demographic data for the participants’ age, 
gender, marital status, education level, if they studied science at a higher education 
level, employment status, if they work in science, income, their ethnicity (categories 






Figure 8: Age by Group 
 
Age varied considerably within each group, however, if the mean is calculated for 
each age range selected by the participants, and the average is then taken for each 
group, the genealogy group has an average age of 37 whereas the health group has an 
average of 38.5. 
Therefore, though there is a high degree of diversity within each group, across 
the groups, there is a similarity in the average age. However, given the sample size, 





Figure 9: Gender by Group 
 
Gender among the genealogy group was split evenly with 50% being male and 
female; however, in the Sequencing.com group, there were six (66.7%) females and 
three (33.3%) males. This difference may be important when defining the target market, 
but given the sample size, more research is needed to determine if this is representative 
of the consumer market. 
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4.5.3 Marital Status 
 
Figure 10: Marital Status by Group 
 
Marital status was skewed significantly with eight (80%) of genealogy participants 
having never been married compared to three (33.3%) of the Sequencing.com 
participants having never been married. This difference may be important when defining 
the target market, but given the sample size, more research is needed to determine if 




4.5.4 Highest Level of Education 
 
Figure 11: Highest Level of Education by Group 
 
Education level varied considerably within the genealogy group, however, less so 
in the Sequecing.com Health group. Furthermore, though there are varying degrees of 
diversity within each group, across the groups, there is a similarity in the level of 
education. In both groups, full the majority of participants did complete higher education 
degrees, which does seem to align with early adopters often having higher degrees of 
education. This difference may be important when defining the target market, but given 
the sample size, more research is needed to determine if this is representative of the 




4.5.5 Studied Science 
 
Figure 12: Studied Science by Group 
 
Of the demographic variables, studied science was one variable which varied the 
least between groups, with both groups demonstrating a similar percentage of 
individuals who did and did not study science at a higher education level.  This was 
explored because it was thought that it might influence how individuals came to be 
aware of DTCG testing, or how they perceived it. Understanding if studying science 
influences consumers may be important when defining the target market, but given the 





4.5.6 Employment Status 
 
Figure 13: Employment Status by Group 
 
Employment status varied considerably within the Sequencing.com health group, 
however, less so in the genealogy group. In both groups, full-time employment did 
represent the majority, which does seem to align with early adopters often having higher 
degrees of disposable income. This difference may be important when defining the 
target market, but given the sample size, more research is needed to determine if this is 




4.5.7 Work in Science 
 
Figure 14: Works in Science by Group 
 
Of the demographic variables, works in science was one variable which varied 
the least between groups, with both groups demonstrating a low percentage of 
individuals who do not work in science. This was explored because it was thought that it 
might influence how individuals came to be aware of DTCG testing, or how they 
perceived it. Understanding if working in science influences consumers may be 
important when defining the target market, but given the sample size, more research is 






Figure 15: Income by Group 
 
Income varied within both groups. However, the Sequencing.com group showed 
slightly greater variation, including being slightly skewed to higher income, which does 
seem to align with early adopters often having higher degrees of disposable income. 
This difference may be important when defining the target market, but given the sample 







Figure 16: Ethnicity by Group 
 
Ethnicity varied greatly with the genealogy group having three (30%) mixed 
ethnicity participants, three (30%) black, African American participants, and four (40%) 
white, European descent participants.  The Sequencing.com group, on the other hand, 
was made up of one (11.1%) mixed ethnicity participant, one (11.1%) black, African 
American participant, and seven (77.8%) white, European descent participants.  This 
was explored because it was thought that it might influence why genealogy consumers 
take the tests given that there is a large component of genealogy research that relates 
to group identity. But given the sample size, more research is needed to determine if 





Figure 17: Urban vs. Rural by Group 
 
 The majority of participants lived in an urban environment, however the 
genealogy was slightly more urban. This difference may be important when defining the 
target market, but given the sample size, more research is needed to determine if this is 
representative of the consumer market. 
 
4.6 Semi-Structured Interviews and Observations  
A total of nineteen participants took part in this study. Ten of them had previously 
used genetic testing for genealogy services at least once, and nine of them had 
previously used Sequencing.com to analyze their DNA for health purposes at least 
once.  
The genealogy group participated in virtual semi-structured in-depth interviews 
which were conducted via the screen share and conferencing service GoToMeeting. 
The audio was recorded for the genealogy participants, but no video.  The 
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Sequencing.com group also participated in virtual semi-structured in-depth interviews, 
but the research session also included an observational component to gain a greater 
sense how participants make use of Sequencing.com in context. These sessions were 
conducted and recorded via the screen share and conferencing service GoToMeeting. 
The audio and video were recorded. The video which was recorded involved a screen 
capture of the user’s monitor, and not of the user itself.  
The interviews and observations followed a guide that sought to foster a natural 
conversation to uncover unknown insights. Throughout this research, the participants 
shared their past experiences, beliefs, values, perceptions, and concerns regarding 
DTCG, both as it relates to specific tests they had taken, as well as its larger role in 
society. At no time throughout the process did any participant skip a question, though 
they were made aware that if they felt uncomfortable with any question, they certainly 
could do so. Similarly, no interview or observation was cut short for any reason. 
 
4.7 Qualitative Analysis  
Qualitative analysis is the process by which social scientists make sense of the 
qualitative data they collect.  It is inherently interpretive as it involves “reducing peoples’ 
words to the researchers’ words about the meaning of their words or actions or artifacts” 
(Bernard 2006, 452).  However, it is my no means an unstructured or unguided process 
despite the data itself initially being unstructured. In fact, it is a very deliberate process 
with the goal of creating a structure that helps to explain the data.  To accomplish this, 
researchers iteratively work through a cognitive process intended to find emerging 
themes in the data. This process requires “researchers to notice, define, describe, 
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count, compare and contrast, and match up things in the data that go together” 
(LeCompte and Schensul 2012, 92). Through this process, the researcher begins to 
retell the story based on how they see the relationship between the emerging themes 
and how those themes are situated in and related to the larger sociocultural context so 
that the deeper meaning within the data can be extracted and made shared.  
 In this research, thematic analysis was the qualitative method used to make 
sense of the qualitative data. Thematic analysis is a process for encoding qualitative 
data with codes. The codes are often descriptive, and then built up into a list of more 
interpretative themes. “A theme is a pattern found in the information that at the minimum 
describes and organizes possible observations or at the maximum interprets aspects of 
the phenomenon” (Boyatzis 1998, vii).  
Thematic analysis was selected as a method because it is not a methodology 
tied to a specific theoretical or epistemological position like thematic discourse analysis, 
thematic decomposition analysis, IPA, and grounded theory. This is not to say that it is 
atheoretical, it is simply flexible in its choice of a theoretical or epistemological 
paradigm. Within the broader body of thematic analysis knowledge, there are various 
perspectives of how it should be carried out.  
Some researchers believe in a top-down theoretical or deductive approach that is 
driven by the researcher's theoretical interests, or even the project goals and research 
questions, especially in applied research. This model of thematic analysis tends to 
provide a detailed description of the data that supports the researcher's theoretical 
interests or project goals, but it is often less of a rich or thick description of the data. 
Other researchers take a bottom-up approach that is more interpretive. In this model, 
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the themes produced may have less of a relationship to the data itself and may provide 
less support in answering the research questions directly, however, the insights 
produced often produce a richer or thicker description with larger sociocultural 
explanatory power (Braun and Clarke 2006).   
 
4.8 Coding Process 
To code the interviews and observation, the audio was first transcribed using 
artificial intelligence natural language processing services to get a base version of the 
text. The text was then cleaned by the researcher for errors and broken up by speakers. 
The text was then exported as a text document and added to a spreadsheet for coding.  
An initial top-down descriptive approach was carried out on a subset of the interviews to 
develop a working descriptive code template in the spirt of template analysis, which is 
one version of thematic analysis. This template was then used to code the remaining 
transcripts with the descriptive codes.  Following this first coding step, a bottom-up 
interpretive approach was used in the course of this research to begin building the 
codes up into more interpretive themes and subthemes.   
The goal of using a mixed methods approach for coding was to allow for both 
deductive and inductive approaches. The deductive approach was intentionally used to 
explore the specific research questions as it aligns to the theory discussed in the 
literature review. The inductive approach was used to uncover questions and insights 
that could not have been anticipated at the outset of the research. This holistic 
approach was valued because the research sought to understand and address 
immediate concerns as well as future concerns. Immediately, the research seeks to 
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produce actionable design anthropology informed insights that can help 
Sequencing.com better define their target market and whole product concept based on 
Moore’s Crossing the Chasm for getting disruptive innovations adopted. But, the 
research also seeks to understand the larger sociocultural context of DTCG as a 
disruptive technology so that a long term strategic intent can be crafted that will support 
Sequencing.com in achieving a sustained competitive advantage as the innovation 
diffuses and the market matures.  
 
4.9 Limitations of the Study 
The potential limitations of the study include, but may not be limited to the 
following: 
∑ The Sequencing.com group, while representative of the company’s customer 
base in that it was about 70% women, is not truly representative of the United 
States and thus may not be fully generalizable to the consumer market. 
∑ The interviews were based on self-reporting which may introduce errors in the 
data collected as a result of a mismatch between what the participants said, 
and what they truly do. 
∑ The observations of the Sequencing.com health group participants were 
carried out virtually, thus limiting the ability to situate the participants’ use in 
the complete context that is also environment aware.  
∑ Triangulation or quantitative measures were not employed in this 
discovery study, and thus the findings may not be accurate or generalizable 
to the consumer market.   
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CHAPTER 5 
FINDINGS AND ANALYSIS 
This chapter details and analyzes the findings of the interviews and observations. 
The chapter is grouped into five major concepts related to the process of diffusion and 
adoption, the experience consumers have taking tests, and perceptions regarding 
potential future harm or ethical issues. 
5.1 How Awareness of DTCG is Diffused 
Bertrand Russell once said “he knows what he has seen and heard, what he has 
read and what he has been told, and also what, from these data, he has been able to 
infer” (Russell 2009, 9). Building on this one might say the ability to adopt an innovation 
is dependent on the ability to learn that an innovation exists. This applies to DTCG as it 
did once to flint axes, but it also applies to ideas or practices of a culture. Therefore, for 
us to begin to understand why a consumer would adopt a DTCG, we must first lean 
about the sociocultural processes that contribute to ideas spreading, and why they are 
adopted. In speaking with the participants, it was found that there were two dominant 
modalities of communication that supported knowledge acquisition, and that kinship and 
social norms played an important role in the awareness of DTCG. 
5.1.1 Gaining an Awareness of DTCG 
Dating back to the Kulturkreis school of diffusionism, anthropologists have 
argued that ideas, or cultural traits diffuse through a process of borrowing that radiates 
out from one or more cores. In the case of the diffusion of innovations, the DOI theory 
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demonstrated that this is often a result of communication that passes from early 
adopters or other figures of authority, to the subsequent adopters. When this happens, 
the potential adopters learn of the innovation, and can begin the evaluation process 
which ultimately leads to the decision to adopt or not. 
Likewise, it is critically important to understand the communication channels that 
play a role in the process of knowledge acquisition. In the DOI, Rogers theorized this 
process was primarily carried out by mass communication (Rogers 2003).  He based 
these ideas on information-flow theory, specifically Paul Lazarsfeld's two-step flow 
theory (Katz and Lazarsfeld 1955). In that model, the social influence of a few peers or 
figures of authority was the driving factor in making people aware of the new 
innovations. The peers or figures, are considered opinion leaders, who after learning of 
new ideas from mass media, spread them to others. Likewise, they have a strong effect 
on adoption during the evaluation stage of the five-step decision making process.  
However, more recent research such as the Hilbert, Vasquez, and Halpern 
communication study cited in the literature review has demonstrated that the two-step 
flow theory model may no longer be the only model for the dispersion of ideas. In their 
research, both one-step and two-step models proved to be effective in transmitting 
ideas, and thus direct mass communication as well as ideas spread by opinion leaders 
played an important role in the process (Hilbert, Vasquez and Halpern 2016). Similarly, 
recent studies of DTCG testing have demonstrated the same. In one study that 
surveyed 3,185 participants, the majority of participants stated they learned of the tests 
through radio, television, and the Internet directly (Agurs-Collins, et al. 2015). In this 
study, both methods were found to be present, and in some cases appeared to work in 
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tandem with one reinforcing the other. Therefore, it does appear to be the case that 
multiple methods of communication play a role in the spreading of knowledge regarding 
DTCG testing.  
In the present study, advertising was the most common modality for becoming 
knowledgeable about DTCG testing. Advertising typically came in the form of internet or 
TV advertisement.  
A lot of advertisements via TV and Internet. (Sarah – Genealogy Group) 
I know that like I didn't really know anybody who had taken it that I remember, but 
I know there was like a ton of ads. (Don – Genealogy Group) 
I was building my family tree on Ancestry.com and I kept seeing, advertisements 
about it. (Vanessa - Genealogy Group) 
Really through online, or not online, but through television ads. It was actually 
purchased for me from my, from my parents as a Christmas gift. So that's how 
we kind and I believe that's how they found out about it through like television 
ads. (Tom - Genealogy Group) 
Yeah, it was like an ad online. I was taking some courses online and I think it just 
popped up as an ad online and I got curious. So I went to look because I had 
been trying to look about our family history and I had heard some things that I 
didn't think were right about our family because my Aunt was doing some 
ancestral research and I didn't think she was doing the right historical research. 
So I got involved in that. (Erin – Sequencing.com Health Group) 
Probably the TV commercials once it became, you know, kind of mainstream and 
easy, easy to access it. (Scott – Sequencing.com Health Group) 
I think just mainly commercials when things like Ancestry and 23andMe came 
out. That was probably my first experience with even wanting to know more 
about it. (Sandy – Sequencing.com Health Group) 
Social Influence was the second most common modality for becoming 
knowledgeable about DTCG. Social influence most often came from family or friends; 




My Dad did 23andme himself and then announced the fact that I did this at 
Thanksgiving a few years ago and the rest of us kind of got annoyed at him and 
said. Hey, what gives? And we ended up getting him into doing DNA testing for 
the rest of the family. (Amy – Genealogy Group) 
 
I first learned about it through my college. It was my geology class actually 
because we were talking about artifacts and looking at different fossils and things 
and then they mentioned that you can actually look up your own heritage and 
lineage your ancestry on different websites like Ancestry, so that's the first time I 
heard about it, and then they also had different commercials advertise on TV, so 
that's when It triggered in my mind, I just wanted to find out for my own curiosity 
what my lineage was. (James – Genealogy Group) 
 
A lot of people that I follow, well not a lot of people, but people were posting 
videos of their results and so it was kind of making me interested. (Eathan – 
Genealogy Group) 
 
Sequencing I actually saw an ad on Facebook someone had, and someone had 
posted on their ad that this had to be a bunch of hogwash and another person 
who had actually signed up through them said no, actually this is really good stuff 
and posted, all their results that they had run through and said, no, actually I had 
run my Ancestory.com stuff through it and it's actually really good stuff. And so I 
decided to go ahead and, and just run my stuff through it and the results I got 
seemed to be legitimate. (Erin – Sequencing.com Health Group) 
 
I was on a website or on Facebook actually and somebody had mentioned 
Genes for Good that they did free testing and so I signed up for it and I got it. 
(Robyn – Sequencing.com Health Group) 
 
I had some tests done in 2015, it was actually for cholesterol, but as part of that 
he [Dr.] did some genetic testing and so that was my first inkling that we could 
actually get our genes tested. (Brenda - Sequencing.com Health Group) 
 
Interestingly, there was an inversion between the groups with the majority of the 
genealogy group first learning of DTCG testing through advertising, compared to the 
majority of the Sequencing.com health group first learning of DTCG testing through 
social influence. The difference may simply be a result of the different states of maturity 
between genealogy and health tests. This assumption of maturity is grounded in the 
estimated sales figures of leading DTCG companies such as Ancestry who is thought to 
control about 62% of the total DTCG market. (Forbes 2017). Likewise, it is being 
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theorized that the genealogical market is further along on the adoption curve than the 
health testing, and as such, is spending more money on advertising to attract 
consumers. However, more research is needed to understand if there are any other 
sociocultural forces mediating the type of communication that is affecting knowledge 
acquisition. 
 
5.1.2 The Influence of Kinship on DTCG Adoption 
Building on social influence as a broad modality of communication that promotes 
awareness of DTCG testing, the specific influence of kinship was explored. Kinship 
represents the network of social relationships a person is enmeshed in through descent 
and/or marriage. Since genetics are passed down through offspring, the concept of 
kinship is intimately connected to the DTCG genomics. But besides that, the sociality of 
kinship also appears to play a more influential role in shaping opinions that contribute to 
the decision to adopt an innovation or not.  
In research similar to that of Rogers’ early farm innovation research, it has been 
demonstrated that “structural features of the personal communication network - 
particularly connectedness and integration - in relation to kin membership in the 
ownership of the farm do contribute some understanding to the process of innovation 
adoption” (Warriner and Maul 1992, 289). In more recent internet-based research, 
kinship has been shown to increase the willingness of a consumer to provide personal 
information online (Limayem, Khalifa and Frini 2000).   
Similarly, in previous DTCG studies, it has been noted that “the taking of DTC 
tests is typically not the solipsistic activity of an individual person, but something that is 
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done with, or with reference to, family members, significant others, friends, or even 
society as a whole. In this sense, genomic information is personal and social at the 
same time: it is personal, but for more than one person” (Turrini and Prainsack 2016, 5). 
In the course of this research, similar results were found. Participants often cited kinship 
relationships as a factor that led to knowledge acquisition and adoption. Many 
participants spoke of how their parents or siblings took the tests, and as a result, they 
wanted to as well. In fact, they often took the tests together, and parents spoke of 
ordering the tests on behalf of other family members such as their children. To this end, 
kinship was often a motivating behavioral intention for taking the tests because they 
wanted to learn about their genetics for genealogical or health reasons.  
Well my family was interested in it, so I, you know, I learned about, you know, 
what they knew and so it was always sort of talked about. So it was always an 
interest within my family as well. “So it was something I kind of grew up with it, 
you know, uncle so and so or, and so and so, or my cousin's such and such did 
such and such and live so on. So this place and that place, so it was interesting, I 
learned about were all interesting people and I found it kind of fascinating. (Ruth 
– Genealogy Group) 
 
Before the FDA thing, yes because at least when you come from a good family 
situation, you trust your parental figures, so based on that and the fact that I was 
in law school at the time and that they couldn't do a product that is bad, because 
of a products liability that is dangerous, that I trusted that they were going to, 
provide me with the results that were probably accurate and thereby helpful. 
(Amy – Genealogy Group) 
 
Doing my own research. Also my grandfather used that website as opposed to 
Ancestry. He had a good experience with it… Wanting to know more about my 
background. I'm not really one hundred percent sure about it. My family, they 
only really had a rough idea of our our roots. Yeah. So, when my grandpa did it, 
that's really what interested me could go on and do it myself.  (Vanessa – 
Genealogy Group) 
 
It was actually purchased for me from my, from my parents as a Christmas gift. 




Yeah, it was probably initially talking to someone. I don't think I saw an 
advertisement about it. Then I probably read some articles on it after that. 
Newspaper articles. But initially it was probably talking to friend or family 
member. (Alex - Sequencing.com Health Group) 
 
My sister, she's interested and because of me she joined the 23andMe and she's 
doing the research but she's not putting everything on the Internet. That's her 
choice. But she's interested in as well. So I'm always showing her what little I 
know and she finds a couple of things I didn't know. Anything I find out well it 
applies to her 50 percent. So she's always interested in that. (Scott - 
Sequencing.com Health Group) 
 
Well for my boys, they were both incredibly lactose intolerant when they were 
babies. We had real issues when we were trying to feed them when they were 
children. Horrible, horrible, horrible issues. And I mean we figured it out pretty 
fast, but then when we did the genetic testing on lactose intolerance, which was 
one of the free ones, it showed that they had, I complete genetic intolerance to 
lactose. Which makes total sense. Perfect sense because they still can't have 
any lactose and it just, it was kind of nice to have that test come through. 
Because the rest of my side of the family, we have no problems with that, but my 
two boys have a total problem with it and they've had problems their entire life. 
So it's kind of nice to see that verification just because they almost died because 
of it. (Erin – Sequencing.com Health Group) 
 
Actually I am in a same sex marriage and we are wanting to have children and 
I'm just interested in both of our genetic make when choosing a donor and trying 
to maybe eliminate some of those illnesses or diseases that are our genes may 
carry by offsetting them with a donor who don't know, who don't have those types 
of issues. So that was the original, I guess medical necessity for us before we 
have kids or before we started the context of doing that. (Sandy – 
Sequencing.com Health Group) 
 
I knew that my maternal grandmother had some half siblings that she had lost 
contact with and that was my main motivation. I wanted to see if I could find 
those people or their descendants and I actually did. So that was pretty exciting. 
That was my biggest one. And then just sort of the health things I thought would 
be interesting. (Claire – Sequencing.com Group) 
 
This study found that both advertising and social influence were effective as a 
communication method to diffuse DTCG testing; however, of those, social influence by 
way of kin appeared to be the most powerful force. For not only could it produce 
awareness of DTCG testing, but it also appeared to enhance the sociality of the 
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process, and as the next section demonstrates, trust as well. Therefore, I argue that 
both advertising and social influence can and should be employed when marketing 
DTCG testing; to the degree that kin relations can be leveraged to influence adoption, 
they will increase effectiveness. Thus when defining a target market, it would be ideal to 
focus on the kin of previous adopters. 
 
5.2 An Ecology of Trust: Science, Social Influencers, and Promissory Knowledge  
Building on Rogers’ DOI theory, other researches have sought to incorporate 
additional dimensions to the model to better understand the decision to adopt. One 
addition to the body of knowledge has focused on trust. Trust is broadly speaking a 
belief in the reliability or trust in something (Dictionary.com n.d.). Trust is especially 
important for e-commerce-based business models because typically consumers lack 
the human interaction they are accustomed to in traditional brick and mortar 
experiences. Furthermore, research has shown that online trust partially mediates 
consumers’ behavioral intent, which is a key factor for adoption in the DOI (Bart, et al. 
2005).  
Given this, researchers have attempted to define what embodies online trust. 
While there are many definitions, Bélanger et al. (2002) defined trustworthiness as ‘the 
perception of confidence in the electronic marketer’s reliability and integrity” (Belanger, 
Hiller and Smith 2002, 252). This definition was used in the course of this research for 
two reasons. First, because DTCG testing is sold through e-commerce websites, and as 
a result, potential consumers need to have trust in the scientific claims that are being 
made on websites and/or advertisements. Second, because genomics is a highly 
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specialized and deeply complex science that most people are not formally trained in, 
and in the past, the reliability, or clinical validity of the tests has been called into 
question (Hogarth and Melzer, 2008). Given this, the research sought to explore 
consumers’ trust in the DTCG products. They were probed about their trust in the claims 
of the DTC companies, as well as their trust in the results and science at large. 
 
5.2.1 Trust in the Scientific Claims 
In the United States people often do receive some form of health education 
during the course of their primary or secondary schooling; however, far fewer receive 
instruction regarding genetic education. Therefore, a small percentage of the population 
has any significant degree of genetic literacy, or the capacity to obtain, process, 
understand, and use genomic information for health-related decision making (Hurle , et 
al., 2013).  
Despite that, a 2018 research study by the National Science Board demonstrated 
that Americans overwhelmingly support science and scientists (National Science 
Foundation 2018). In this study, only four out of the nineteen participants had studied 
science (biology, chemistry, or similar) at a higher education level, yet all of the 
participants had opted to take one or more DTCG tests; and in the case of the 
Sequencing.com participants, they had often analyzed their data using multiple web-
based services. When asked about the claims the DTCG companies were making, the 
majority of the participants had a favorable view of the scientific claims outright, or after 
a brief bit of online research. Interestingly, in the responses, some participants stated 
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that they believed in the process because it was science based, while at the same time 
acknowledging that they didn’t understand it. 
One such participant, Don, articulated this best.  Don is a millennial who has only 
acquired some college education and is working part time. He is not married and 
earning less than $30,000 per year. He has not studied science and does not work in 
science.  He became aware of DTCG testing through an advertisement and was not 
influenced by kin. Though he admits he does not understand the science, he feels the 
companies are sure about the science, so he trusts in that. 
Yeah, I mean I was like, you know, I think it's all about genetics, so it's not 
something I personally understand, but these are companies that do genetic 
testing, like they seem pretty sure. You know, like scientific facts. (Don – 
Genealogy Group) 
 
Other participants were less open about their potential lack of literacy, but were 
no less positive about the scientific claims. 
I understood that the science behind it made sense. Like logically you could tell 
from DNA what your heritage is. So I trusted the science as well as the 
testimonials. (Toby – Genealogy Group) 
 
Well, I didn't think it could be something as simple as done online. I thought it has 
to be like a whole lab procedure, where they draw blood, swab your mouth and 
look at your DNA, run some tests that'll take weeks only and it was like a whole 
procedure, but I just filled out the form online and it just broke everything down. 
For me it was, I thought it was going to be a whole drawn out process, but it 
actually wasn't. (James – Genealogy Group) 
 
Initially, I thought that it is cool that you could just simply spit into a tube and get 
us to the genealogy or health information at your fingertips. That's very 
progressive and hopefully helpful and later medical decisions you would make. 
(Amy – Genealogy Group) 
 
I'm probably slightly skeptical just because I don't necessarily know the number 
of respondents or the number of data points that they're comparing to. I'm sure it 
would say, but I'd have to actually look. But for the most part I feel like especially 
if something does have a good base of research that in general I can probably 
trust it. (Claire – Sequencing.com Health Group) 
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I think I was little bit skeptical, but when I clicked the ad and I read into it more, it 
seemed pretty straight forward. I mean, you just send your saliva and that's it, 
you know, and wait for your results. I didn't have any limitations about wanting to 
do it. (Vanessa - Genealogy Group) 
 
I believe science is really, it proves a lot of stuff. I actually started out as a 
physics major in college... I have a very strong belief in it and you know cause 
my life started out that way. My father's an engineer, my sister's an engineer, so I 
do believe in logic. I believe in science. I believe in math and I'm encouraging my 
boys to go that way. (Erin – Sequencing.com Health Group) 
 
Just spit in the bottle and find out about your heritage and maybe some health 
things. So I thought it pretty neat.” (Scott – Sequencing.com Health Group) 
 
5.2.2 Trust in Online Social Influencers 
Many participants appeared to put trust in the claims as a result of online social 
influences. Online opinion leadership can come in many forms. Historically, user-
generated content (UGC) such as online reviews or forum posts were the primary 
modes of influence on the internet. However, in more recent years, brand ambassadors 
and social media influencers are also starting to play an important role. Interestingly, in 
almost all cases, these online social influencers do not share an immediate connection 
or relationship to the consumer, and yet, consumers often form their opinions as a result 
of what they read.  
 In this study, online reviews played an important role. Online reviews are part 
online reputation systems that allow consumers to share their thoughts and provide 
feedback on a product or service (Resnick, et al. 2000). Previous research has shown 
that consumers make significant use of online reviews when making a decision to 
purchase or not. In fact, in a 2010 survey of U.S. internet users 92% stated that they 
read online product reviews and 89% of them stated that product reviews influenced 
their product choice (Freedman 2008). In this study, participants made similar 
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statements. Interestingly though, almost all of the participants that did were part of the 
genealogy group.  
Eathan, an African American full-time employed, married Gen Xer, summarized 
the trend of looking for reviews best. As he stated, he reads reviews before buying 
anything online. For Eathan, the volume of stories on Amazon was important, as was 
the ethnic diversity of respondents. 
What I do is when I buy anything, I always read reviews. So, I went to Amazon 
and I was surprised they sold it on Amazon and then there was a lot of reviews. 
Like, I think Ancestry had like thousands of reviews and it was mostly positive. 
People were writing long reviews saying it's very well done, you know, it's pretty 
good. They're giving pros and cons, but most of it was positive reviews. And all 
types of people, you know, European people, African people, all types. So I kind 
of had a good feeling because it was getting good word of mouth from the 
reviews. (Eathan – Genealogy Group) 
 
Many of the other participants did not read as many reviews, or specify the same 
criteria of volume or diversity as Eathan; however, they too deemed the opinion of 
others to be important. 
For the most part because we read some online reviews as well and saw that it 
was like legit, it wasn't like a scam or anything like that. So I mean, you know, 
just looking at some different online reviews or you know, reading an article 
about it, you know, kind of looking at it a little bit more and you know, it seemed 
like a legitimate, a illegitimate deal. (Tom – Genealogy Group). 
 
I wanted to make sure they would keep my genetic data private and safe and 
secure. Once I, you know, I read a couple reviews on it once I made sure that, 
that, that was the case, then I didn't have any qualms about using the site. (Alex 
– Genealogy Group) 
 
So when there was some kind of a sale or a special and I kind of looked at all the 
DNA tests and this particular one had pretty good reviews. So I was like, OK, well 
let me just do that. (Tracy – Genealogy Group) 
 
I read a couple reviews on it once I made sure that was the case, then I didn't 
have any qualms about using the site… I looked at a different articles, different 
forums for people who had used it previously or were currently using. It's kind of 
different reviews out there. (Alex – Sequencing.com Health Group) 
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Other participants did not reference online reviews, but other forms of online 
opinion leadership such as testimonials, social media comments, and webinars that 
acted as a social influence on their decision to adopt. 
The advertisements use personal stories of people who have actually gone 
through the process and found out interesting things about their heritage that 
they didn't know. And I understood that the science behind it made sense. Like 
logically you could tell from DNA what you're heritage is. So I trusted the science 
as well as the testimonials. (Toby – Genealogy Group) 
 
I would say probably on YouTube probably the first time I heard about it. and like 
two years ago, I feel like maybe two and a half years ago... Yeah. A lot of people 
that I follow, well not a lot of people, but people were posting videos of their 
results and so it was kind of making me interested in and aware of the products 
that you actually could buy the kit and get your DNA tested. (Eathan – Genealogy 
Group) 
 
Sequencing I actually saw an ad on Facebook someone had, and someone had 
posted on their ad that this had to be a bunch of hogwash and another person 
who had actually signed up through them said no, actually this is really good stuff 
and posted, all their results that they had run through and said, no, actually I had 
run my Ancestory.com stuff through it and it's actually really good stuff. And so I 
decided to go ahead and, and just run my stuff through it and the results I got 
seemed to be legitimate. (Erin – Sequencing.com Health Group) 
 
It was actually the, that Webinar I mentioned, I hadn't realized still that you could, 
that there were sites that you can upload your raw DNA data to and get health 
information back from it. I was thinking, that I would just have to talk to a doctor 
about it who explain different things were... One of the things she talked about 
was just sort of lifestyle things like, you know, what would be the best kind of 
exercise and, you know, should you be drinking caffeine or not and that kind of 
thing. So that peaked my interest, but I do have some genes that popped up that 
concerned me and I thought, wow, I really need to research this some more and 
this could be a good first step. (Brenda – Sequencing.com Health Group) 
 
I was on a website or on Facebook actually and somebody had mentioned 
Genes for Good that they did free testing and so I signed up for it and I got it. 
(Robyn – Sequencing.com Health Group) 
 
5.2.3 Trust in Claims of Promissory Future-Oriented Knowledge  
Other participants appeared to be less trusting in regards to the science claims of 
the DTCG companies but were still willing to try the DTCG tests based on the belief that 
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they might learn something interesting about themselves. Though hesitant, they 
expressed hope or the desire to learn cool stuff.  
In previous literature, the exchange of genomic data for potential future value is 
considered representative of the promissory capitalist model of the new bioeconomy. In 
the case of DTCG, that model is grounded in the concept of future-oriented knowledge, 
which is based on the assumption that over time consumers will be able to learn 
increasingly more about themselves as more people share their genomic data, since the 
predictive power should rise with more data. The belief that over time there will be more 
predictive power is grounded in the ability to conduct statistical analysis of genomics at 
the population level.  It is a perspective that can trace its roots to the concept of 
medicalization. A corollary to medicalization in our modern technoscientific molecular 
era is geneticization. 
Geneticization is a term used to describe the “expansion of health and illness via 
genetic technologies; differentiation of individuals on the basis of genetic variation; 
construction of biological phenomena through inappropriate labelling of health and 
disease as ‘genetic’ rather than social, structural or environmental; political economy of 
disease prediction and prevention; and socio-cultural expectations that reinforce the use 
of genetic technologies, especially in the context of women’s reproductive choices” 
(Arribas-Ayllon 2016, 133). In our increasingly geneticized world, patients have become 
consumers who believe through commercial transactions they can understand 
themselves fully by way of genomic analysis. In this study, numerous participants 
embodied the hope and spirit of the promissory economy, even in many cases without 
the ability to verify the reliability of the science that their trust ought to be based on. 
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The lore of future promises was most interestingly described by Tracy.  She is an 
African American who feels her identity, as well as the history of her people were ripped 
from them as a result of slavery. She passionately wants to learn more about her 
identity, and wants to believe the claims of the DTCG companies. For her, it would be a 
dream come true to learn more about herself as a result of her genetics, and trusts out 
of hope in the potential future knowledge she may learn. 
You know, I was like, I don't know, I don't, I don't know for sure and knew like it 
could've been a possibility and I was clinging to the hope that it was true. So it's 
kinda like, it's kinda like a child's fantasy when they say, you know, you're gonna 
meet this princess and even though you may not ever meet the fairy princess, 
you always, you always dream about the possibility of meeting that very princess 
or growing wings and flying off or meeting ferry and stuff like that. So it's always 
that hope and that dream kind of like childlike behavior. And so I wanted it to be 
true, but I don't really know. (Tracy – Genealogy Group) 
 
Most other participants were far less passionate in articulating why they trusted 
the future promises, but nonetheless felt it was worth doing to potentially acquire that 
knowledge. 
Well, when I first read it, I didn't have much. I was like, I was kind of. How can I 
say. I was like, I didn't believe it. I don't believe it, I'm like no. Like no this can't be 
for real. Like no. These tests, no how accurate are these. Like, I didn't believe in 
it. You know what I'm saying, they can't be real. Only way to find out if it's real, so 
some of your heritage and then do it. (Sarah – Genealogy Group) 
 
You can't trust everything, you know, until you just make yourself a test dummy. I 
figured it would be a good shot to be something to learn from. Especially 
something about myself that I didn't know. So I just gave it a shot man. Why not? 
I got nothing to lose. (James – Genealogy Group) 
 
I mean a lot of it is hypothetical and theoretical, so, I'm just interested in seeing 
how far we can advance. (Scott – Sequencing.com Health Group) 
 
I think you know, at the time it was, it was newer and at the time I was a little 
skeptical that it would be able to give you results that accurately reflected your 
risk, since it was so new and there was I guess limited amount of information at 
the time among other people and then genetic testing overall. But now as, as it's 
been a few years now and there has been more people who have done these 
81 
 
tests and there's a lot more data they can correlate different risk factors, I'm 
becoming more confident in the analysis. (Alex – Sequencing.com Health Group) 
 
Not immediately. I certainly did a lot of research just into it in general to see how 
they would sort of be able to use my information because that was my main 
concern. But I was kind of was overruled by all of the cool stuff I could find out. 
(Claire – Sequencing.com Health Group) 
 
I think it makes things a little easier, yeah. I mean there may be things that 
maybe the genomic testing when we might have to do more genetic testing. 
When the genetic testing easier and more accurate, we may have to do them 
again sometimes. Especially when my kids get older, you know, when you might 
have to do it again because I realize science gets better, techniques get better. 
So we're not going to just go with what we've already done, but yeah, I think, I 
think this is definitely this is a, this is the way of the future. If you asked me, I 
think we should just be doing this kind of stuff. (Erin – Sequencing.com Health 
Group) 
 
The two methods examined for building trust proved to be effective in influencing 
consumers to adopt DTCG testing, and given that, some questions arise. Is it fair to 
intentionally appeal to consumers through promises of future oriented knowledge which 
may or may not come true?  Should consumers be listening to social influencers who 
themselves likely came to believe the claims through the same process earlier in the 
adoption curve? Who should be the opinion leaders if scientists and businesses have 
previously demonstrated cooperation through the process of medialization?  
While this thesis may not be able to answer those questions universally, it does 
suggest that when marketing DTCG products, it would be more ethical from a utilitarian 
perspective to base any claims in the present realities. To that end, companies offering 
DTCG products should describe shortcomings in methods, datasets, or scientific basis 
ought to help consumers make the most informed decisions, given that most lack formal 




5.3 Identity Making: The Body, Others, and Place and Time 
In a 2016 study, Turrini and Prainsack stated that “genetic or genomic data can 
serve as a starting point to tell a story about ourselves, claim a place in the ongoing 
evolution of bio- medicine, or contribute to medical research” (Turrini and Prainsack 
2016, 6). When speaking with participants in this study, that claim proved to be true. 
For the participants in this study, the motivation to take a DTCG test often was 
related to understanding oneself and/or their kin. This interest frequently involved 
concepts of the body, place, and time - the past or the future. In some cases, 
participants were interested in both themselves and their kin, as well as the past and the 
future. Furthermore, a difference between the two groups emerged with the genealogy 
group often very specifically articulating their desire to learn more about family history, 
and the Sequencing.com health group most often stating their interest was personal 
health.  
However, it should be noted that all of the Sequencing.com health group 
participants also took one or more ancestry tests in the past. Taking these tests is the 
method by which they got their genetic data for analysis on Sequencing.com. Given 
this, some of the Sequencing.com participants also mentioned family history as an 
interest.  Similarly, some of the genealogy group used 23andMe as their testing service 
which resulted in them receiving health data, and thus some participants from this group 
also mentioned health as an interest.  
Therefore, while the two groups primarily leaned in one direction or the other, 
there was a degree of overlap in regards to interest, and though the data could be 
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analyzed from a family history versus health perspective, other more salient concepts 
emerged in analysis. 
 
5.3.1 Narratives of Self in Relation to the Material Body 
In medical anthropology, the body is a quintessential unit of analysis that is rife 
with overtones of the physical, psychological, and symbolic. It is at once material and 
ephemeral, with distinct meanings at the cultural, societal, and individual level. To this 
end, concepts of the body are social constructs that grow out of the cultural beliefs of a 
group of people, as Marcel Mauss discussed.  
According to Mauss, behaviors such as acceptable facial expressions and other 
physical acts are largely shaped by the group we live with (Mauss 1973). As such, the 
material body, and the social meanings that are embodied within our understanding of 
it, have varied historically throughout the cultures of the world. And while the diversity of 
thought concerning the body has been demonstrated to be vast, it was not until the past 
60 or so years that the concept of the body took on a distinctly western biomedical 
conception. This trend, which grew out of the conception of medicalization and 
geneticization previously discussed, is resulting in wholly new conceptions of identity 
that are at their essence, biological.  
These new conceptions of self are based on Paul Rabinow’s concept of 
biosociality, or an identity based on genetic or biological conditions.  These conditions 
have the ability to alter one’s own sense of personal identity, as well as the social 
relationships they are part of (Rabinow, 1996).  In this study, it was found that the 
majority of participants echoed these ideas, with participants emotionally speaking 
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about DTCG in relation to who they were, as a result of their genetic lineage and 
makeup. This was found in both the genealogy and health group, albeit in slightly 
different ways, with the genealogy group feeling their genetic identity defined who they 
were in relation to concepts of ethnicity, while the health group framed their identity in 
more of a biomedical way.One participant, Ian, was particularly interested how his 
genetics shapes his unique health and social identity. As a full-time employed married 
millennial working in science, with an undergraduate education in science, he 
articulated this point the clearest.  
I was definitely excited to like learn about what specifically my body or what the 
DNA would say about the things that are unique to me and the family ties or the 
health aspects of it too. It can be within that. (Ian – Sequencing.com Health 
Group) 
 
Other participants, while possibly not as succinct as Ian, also made refences to 
the materiality of their identity of self.  
Just to know my background because you know, anybody can say that you know 
I'm Caucasian or that I'm African American, but they don't know to what extent 
that they are Caucasian and African American. So I just want to know a little bit 
more about my own ancestry and what genes comprise this beautiful specimen. 
(James – Genealogy Group) 
 
Yeah, I mean because again, I came from the sperm bank in New York, you 
know, a specific time in a specific place and the people that were living there 
were, you know, of certain nationalities and because I look so different from my 
mother, I assumed it was like southern European and the people that were in that 
area were Italian and Jewish, so I was like, well I'm probably Italian or Jewish or 
something like that from that area vaguely of the world. (Don – Genealogy 
Group) 
 
I'm curious because I've got some things going on that the doctors can't figure 
out… I thought that could be a way to open up a whole other realm of 
possibilities for them to be able to try to figure out what's going on… Yeah, more 
the medical aspect of it and you know, learning more about what I can do to keep 
inflammation down and get my body to the point where I can do those other 
things, where I can do more than just walking, where I can do exercises without 
having such exercise intolerance that I dropped… I'm not as hard on myself, for 
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things and I'll say, you know, this just, this isn't because I'm overweight or it's not 
because of something else Its this condition that's causing a lot of things to 
happen. And I hate to say it, but you walk into doctor’s office and the first thing 
they do is look at your size and they go, well, you're overweight. You need lose 
weight and that's why you are having all these issues. They don't go into the 
underlining, you know, neurological issues or anything like that to see what's 
going on. (Robyn – Sequencing.com Health Group) 
 
I was interested in what genes were responsible for, you know, the susceptibility 
for different diseases… I'm just being aware of certain things that I am, you know, 
I guess more likely to experience just based off of my genetics. (Sandy – 
Sequencing.com Health Group) 
 
5.3.2 Narratives of Self as Part of a Group 
Building further on the concept of biosociality, it was observed that participants 
often spoke of wanting to learn more about themselves as a function of learning more 
about others. However, the notion of the other was not used in the reductive sense of 
“othering.” In fact, the participants were referring to members of their “us” group, 
typically kin or distant members of their assumed ethnic clan. Many of the participants, 
particularly in the genealogy group, felt that by understanding their family history and 
ethnicity, they were better able to understand who they were. 
For many of the participants, this sense of wanting to know about their “us” group 
was further amplified by feelings of uncertainty given life circumstances. One 
participant, Don, aptly demonstrated this. Don grew up in a house with a mother and 
father, however his father was not his biological father, given that his mom went to a 
sperm bank. As a result of this, he longed to understand his identity through the lens of 
his father, but he also longed to find others who shared this narrative of being a sperm 
bank child. Through DTCG testing he was able to find out about his father’s ethnic 
identity, as well as network with others who fit the sperm bank child persona. 
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Well for me personally, my mom went to a sperm bank to be impregnated with 
me so I didn't know what my ethnicity was on my paternal side. So that was like 
the, for sure the main factor… now I more understand, there's other people like 
me out there who like had paternal sides they didn't know about who came from, 
you know, the same situation. I don't know anybody else with my story quite my 
story and now I have, you know, at least two half siblings that I know of who 
share a very similar story and share the same father. (Don – Genealogy Group) 
 
Similar to Don, many of the other participants shared stories of uncertainty as a 
result of not knowing the history of their parents given challenging life circumstances, or 
in some cases simply because of a lack of generational knowledge about the family 
ancestry.  
Mine was to find out you know more history on my background because my 
parents are addicts. So, I really wasn't raised by them so I don't know much 
about my background. I just knew I was Black, Mexican or Filipino. And I said 
well, there's gotta be more to it. You know just out of curiosity I did it… It was just 
to find out my ethnicity. I wanted to see what type of bloodline I come from given 
my DNA. (Sarah – Genealogy Group) 
 
I was interested because I wanted to learn more about my family's background in 
terms of where we may have come from as well as the health aspects, that I may 
or may not have been more at risk of. … Because my father is Jewish and my 
mom is Episcopalian I wanted to see where my ancestors came from both from 
the Jewish side point of view, even though I'm not Jewish because my mother's 
not Jewish, I consider myself Jewish regardless of that. And I wanted to see 
where the rest of the family came from… Yeah. I have a medical condition that 
affects us. Well it affects anyone, but it affects Ashkenazi Jews, my particular 
gene or whatever, that I could understand of it, affects more Jews than other 
people. (Amy – Genealogy) 
 
I thought it was really interesting. I've always been curious about my ancestry 
and my roots, so it's definitely something that appeals to me usually I don't 
respond to ads, but that actually did that time… Wanting to know more about my 
background. I'm not really one hundred percent sure about it. My family, they 
only really had a rough idea of our our roots. Yeah. So, when my grandpa did it, 
that's really what interested me could go on and do it myself… Yeah, my mom's 
side of the family, they've always suspected that their French Canadian. So, I 
wanted to verify that myself and it did come back to be true, to some extent. 
(Vanessa – Genealogy Group) 
 
I mean I thought it was a neat process because we always assume where we 
were from or you know, where our heritage was or whatever else. And then this 
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could either confirm it or kind of peak some interest. Cause I know that my 
grandmother, my maternal grandmother was adopted. And so, you know, there's 
always some uncertainty there. You know you never know where you might 
come from. It was just kind of a neat idea to kind of really, you know, kind of hone 
in on where, where we came from. (Tom – Genealogy Group) 
 
I thought, I thought it could be a really interesting from a health perspective. I 
thought I would want to know if there was anything high risk I should be 
concerned about. Anything along those lines cause my, my father is adopted. So 
there's kind of an and unknown in that area… Like I said, my father was adopted. 
It's like an unknown area. He has a couple issues, but beyond that we don't really 
know what kind of medical history his side of the family has. So I thought it would 
be, it'd be great to kind of get to know that especially I now have a daughter and 
it would be good for her to know as well. (Alex – Sequencing.com Health Group) 
 
We did the genome testing through ancestry.com because we actually live just 
next to a large Indian reservation and my kid's dad had told us that he had native 
American blood in him and here it's very big thing to know whether you have 
native American blood in you. So we needed to know whether we had native 
American blood in my kids. And then when I found, that Sequencing app online, I 
thought it would be a good thing to know more information because my kids were 
preemies and we had a lot of health issues with them when they were children 
and we had done testing on one of the kids. So I figured I would run everything 
through the available Sequencing apps that we were able to afford. (Erin – 
Sequencing.com Health Group) 
 
 
5.3.3 Narratives of Self in Relation to Particular Places and Times 
In participants’ narratives, their material body and their “us” group were often 
situated in relation to particular places and times to further define their identity. For 
many of the participants, there was a deeply historical aspect to how they perceived 
themselves to be, as a direct result of the trials and tribulations of their ancestors. For 
some, particularly African Americans, the concept of lost time or history under the 
bondage of slavery was the most prevalent idea. However, family members coming 
from a distant geography for other reasons were also mentioned. 
One participant, Tracy, most poignantly and passionately described her lost 
history as an African American.  For her, the concern was not only immediate, but also 
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historical, as the structural violence carried out as a result of slavery has resulted in 
both the loss of her connection to her early American roots, but also the loss of 
connection for her ancestors to their African roots.  
I wanted to understand more of my ethnicity because African Americans, our 
history was lost. It's been decimated. And some part of me wants to know where 
I came from and where my ancestors been. Just because as an African 
American during the slave period, our history was ripped from us. We don't have 
that, that sense of legacy and so understanding where we've been gives, I guess 
gives a little bit of piece of my journey. My ancestors previous journey throughout 
the years. And so having that understanding that sense of self-worth and that 
we're more than just slaves. (Tracy – Genealogy Group) 
 
Similar to Tracy, the majority of other participants in this group spoke of this 
particular problem with African American history; however, a similar problem of 
historically oppressed people was also found with Ruth discussing her family’s Jewish 
heritage in Europe. 
Because of my particular heritage, a lot of records were lost or destroyed. So I 
was just hoping somehow, or somehow some way it could be found. (Ruth – 
Genealogy Group)  
 
Well personally in my case is I'm mixed. My father is African American and my 
mother is Korean. So that being said, I think it's a little harder to know your 
ancestry, especially being black in the United States. So I was kind of curious to 
see what will come back because we don't always know like, you know, a full 
family tree and you know, what countries we came from in Africa, etc. So it kind 
of was curious from me being what I am… Yeah, because really that was one of 
the main reasons too that I was interested in doing it was because my father, he 
passed away a years ago, but when he was alive he was not very, he didn't do a 
very great job of like really telling us about our roots and stuff. He really didn't tell 
us everything about our family. So we kind of were in the dark a lot of things. And 
because of our last name, I know a lot of Jamaicans have that last name, 
because I've met Jamaicans and they heard my surname, they said, oh, that's a 
very popular name in our country. So I was curious if they had more Caribbean 
roots. (Eathan – Genealogy Group) 
 
I should do it and see what all I'm made up of I guess. I think for me, because I 
am African American, I don't have it, I don't have as much information as far as 
heritage goes where I can like trace my lineage back generations. I can only go 
back a certain number of generations before there is like no information. So it 
89 
 
was just interesting to me to want to get that information based off of my 
genetics. (Sandy – Sequencing.com Health Group) 
 
Identity was demonstrated to be a crucial factor for choosing to adopt DTCG 
testing, be it for genealogy or health purposes. Given this, it is theorized that narratives 
of identity, along with the related concept of kinship, appears to be a fertile ground for 
appeals to consumers for use in advertising and language on the website. However, 
given the previous section concerning trust, it is also advised to not overstep or over 
promise what someone will uncover. Has was demonstrated by most participants, 
especially those in the Sequencing.com group, consumers today appear to go from 
testing service to testing service in hopes of learning more, plausibly as a result of 
shortcomings in the results or, at the very least, the presentation of the results.  
 
5.4 A Biosocial Rite of Passage 
Rituals were broadly defined by Victor Turner as prescribed formal behaviors for 
occasions not given over to technological routine, having reference to beliefs in mystical 
beings or powers (V. Turner 1967). They are known to exist in all cultures, and likewise, 
the study of ritual has been a hallmark of anthropology since its founding (Bell 1997). 
One type of ritual, rites of passage such as marriage or death, represent the transition 
from one state to another.  
Rites of passage, and rituals at large, have been studied through the lenses of 
cultural materialism, functionalism, historicism, postmodernism, symbolic, and other 
anthropological theories for decades. Early leading figures like Durkheim and Mauss 
expounded on the role rituals play in society, and anthropologists since then have pored 
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over their meaning, frequently debating what constitutes a ritual.  But despite the 
debates, one fact few have denied, is the importance of rituals to culture.  
In the interviews, an unexpected finding emerged:  all nineteen study participants 
described sharing the results of their tests with important people in their life.  Their 
descriptions of this sharing moment gave it a ritual flavor, often with considerable 
emotional content. These sharing moments can be regarded as the completion of a rite 
of passage in Van Gennep’s sense (V. Turner 1967). Participants have taken on a new 
identity and are communicating it to their social world.   
Participants shared test results with family, peers, and in some cases people of 
influence. Many of the genealogy participants sounded especially excited when 
describing the process of sharing. While the Sequencing.com health participants mostly 
shared their results privately with their families, participants from the genealogy group 
often did this quite publicly, even going so far to share their results through social media 
to their extended networks.  From a DOI perspective, the sharing ritual may be 
understood as the moment where DCTG users influenced the next wave of adopters. 
Of the participants, Sarah was possibly the most vocal and excited when 
discussing sharing.  For Sarah, an individual who demonstrated a relatively low level of 
genomic literacy throughout the interview, was incredibly interested in sharing her 
personal results with many of her social circles, including on online via Facebook. 
So yeah I've shared my information with everybody, my bosses my co-workers 
my kids my family. I have a Facebook page. I even took a screenshot of my 
results and post on mine. I shared a lot.. Just to put it out there like wow this is 
different. I took this test you guys and it worked. Wow, this might be a good thing 
that they've created. It is here to help us you know connect our long lost family 
members you know and maybe. Later on in years it will be a little bit cheaper 




But Sarah was by no means the only participant to share their personal data with 
vigor. The trend occurred equally throughout both groups, though as stated above, the 
health group was a bit more private in who they choose to share the data with.  
Just whole world knows now it's on Facebook…. It wasn't me necessarily trying 
to share the data. I just wanted to put it out there that there is something out here 
in case you were wondering if it can help you break down your, your, uh, 
ancestry background. So it was more like a free advertising type thing. (James – 
Genealogy Group) 
 
Yeah, I mean I posted it on Facebook. I showed my friends, I took screenshots 
and texted it to people. (Don – Genealogy Group) 
 
I Instagramed, the result and that's where I had to go back to it. (Tracy – 
Genealogy Group) 
 
I just verbally told people about it to…. they were friends but with a similar 
heritage. (Ruth – Genealogy Group) 
 
We share, we share them as a family and we share them with our extended 
family and you know, and even a couple of friends here and there too. (Tom – 
Genealogy Group) 
 
Yeah, the doctor, my twin sister and mother. (Amy – Genealogy Group) 
 
I told my family members about the results. (Vanessa – Genealogy Group) 
 
When I got my 23andMe results, I emailed a pdf of them to all of my immediate 
family members and then my aunts and cousins as well, even though they won't 
get the same results, I thought they'd be interested, especially in the maternal 
haplogroups since they're all on my mom's side then because we would share 
the same one. So some of them were more excited than others, but I am not sure 
how much I know my parents are interested in and getting their testing done. And 
I've done my 92 year old grandmother cause I was like, I just knew I would be so 
upset if something happened and I didn't get a chance to. So, and then my dad 
has just bought some for his parents, so, hopefully they'll get those in pretty 
soon. And that's the other thing I'm looking forward to see what genes came 
from, what parents and then which grandparents since… I thought they would 
find it interesting and I certainly found it interesting. So, I just wanted to share… I 
was certainly excited to share it with my family. maybe I was a little bit 
apprehensive with the doctor just because I wasn't entirely sure what their 
reaction would be. But I did get a pretty good reception, I would say they were, 
they were skeptical but not dismissive. So I thought that was, I don't know, that 
was a pretty good reaction to me. (Claire – Sequencing.com Group) 
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I sent the report to my father because he was interested in some stuff and his 
wife was curious about it and so I sent it in terms of I sent my data as an example 
with explanations on how to interpret certain things. (Sophia – Sequencing.com 
Health Group) 
 
With my friend who was, she was curious what tools were out there. So I was 
sharing to show her an example of what she could get for herself. (Sophia – 
Sequencing.com Health Group) 
 
My family, and I did show my exercise one to my physical therapist. (Erin – 
Sequencing.com Health Group) 
 
Oh yeah, I have. I shared you know everything... I made it open source… If you 
go to Open Humans, I'm there and I shared all the DNA and I got all kinds of 
medical stuff. A lot of personal information in there. (Scott – Sequencing.com 
Health Group) 
 
Since DTCG testing is still a privileged action, given that only an estimated 12 
million US consumers have made use of the tests (MIT Technology Review 2018), the 
process fits Bell’s conceptualization of ritualization (1992). Bell argues that ritualization 
is "a way of acting that is designed and orchestrated to distinguish and privilege what is 
being done in comparison to other, usually more quotidian, activities”  (Bell 1992, 74).  
 
5.5 The Current User Experience Landscape 
User experience “encompasses all aspects of the end-user's interaction with the 
company, its services, and its products” (Nielsen Norman Group n.d., para 1). To 
achieve this, a design needs to meet the user’s exact needs without any difficulty. But, it 
also goes beyond this basic premise. A good user experience also ought to delight the 
user. To deliver a good user experience, designs need to execute on critical aspects of 
the experience or interaction consumers will have with a product (Nielsen Norman 
Group n.d.).  
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One such critical aspect is utility.  Utility is based on whether or not the product or 
service provides the features you need. Building on that is the concept of usability. 
Usability is indicative of how easy or pleasant something is to use (Nielsen Norman 
Group n.d.).  It is important to any product or service but is intimately important to 
something like DTCG testing given how disruptive it as. For as Christensen theorized, 
disruptive innovations which are defined by competence-destroying discontinuities, 
require new skills, abilities, and knowledge; and therefore, require more effort on the 
part of the consumer (Christensen 1997).  
Utility and usability come together and dictate how useful a product or service is. 
Usefulness is important because it contributes to why consumers adopt, if they continue 
to keep using the product and if they recommend it to others (Nielsen Norman Group 
n.d.). Thus, it intimately relates to the decision, implementation, and confirmation steps 
of Rogers’ DOI theory. The research sought to gauge the participants’ perceptions 
according to these concepts. 
 
5.5.1 Utility and Lack of Information 
The concept of utility is grounded in solving the need of a user. To that end, it is 
related to features a product or service, as those features are the functional aspects that 
can address the user’s needs. In this study, the need the participants were looking to 
solve primarily echoed the sentiments captured above in the identity section. Per those 
findings, the primary goal of the participants was to learn more about themselves from a 
genealogical and/or health perspective. This applied to applied to all nineteen 
participants. The only other forms of utility voiced by the participants were to find 
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relatives. However, only three participants mentioned this in the course of the research, 
and one other participant mentioned contributing to science. 
I was intrigued and interested in and I thought it would be really cool to find out 
more specific detail about my genetic history and my heritage. I kind of had a 
general idea of where I'm from, but I thought it'd be cool to find out more specifics 
and maybe find out something that I didn't know. (Toby – Genealogy Group) 
 
Well for me personally, my mom went to a sperm bank to be impregnated with 
me so I didn't know what my ethnicity was on my paternal side. So that was like 
the, for sure the main factor. (Don – Genealogy Group) 
 
I wanted to understand more of my ethnicity because African Americans, our 
history was lost. (Tracy – Genealogy Group) 
 
I was interested because I wanted to learn more about my family's background in 
terms of where we may have come from as well as the health aspects, that I may 
or may not have been more at risk of. (Amy – Genealogy Health Group) 
 
I'm curious because I've got some things going on that the doctors can't figure 
out… I thought that could be a way to open up a whole other realm of 
possibilities for them to be able to try to figure out what's going on… Yeah, more 
the medical aspect of it and you know, learning more about what I can do to keep 
inflammation down and get my body to the point where I can do those other 
things, where I can do more than just walking, where I can do exercises without 
having such exercise intolerance that I dropped… I'm not as hard on myself, for 
things and I'll say, you know, this just, this isn't because I'm overweight or it's not 
because of something else Its this condition that's causing a lot of things to 
happen. (Robyn – Sequencing.com Health Group) 
 
I thought, I thought it could be a really interesting from a health perspective. I 
thought I would want to know if there was anything high risk I should be 
concerned about. (Alex – Sequencing.com Health Group) 
 
I was interested in what genes were responsible for, you know, the susceptibility 
for different diseases… I'm just being aware of certain things that I am, you know, 
I guess more likely to experience just based off of my genetics. (Sandy – 
Sequencing.com Health Group) 
 
Some participants were left wanting more information after getting their results, 
which mirrors the finding that many of the participants used multiple DTCG testing 
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and/or analysis services. The concerns were that there was a lack of data, or the data 
was not explained sufficiently, and thus it did not address their need.  
I think it just seems like, you know, the basic stuff was like, oh, I'll like know what 
percentage of like what ethnicity I am and there's other information that I don't 
really understand or care to. (Don – Genealogy Group) 
 
If it can build like, it does go into detail, but like a more descriptive like pinpointing 
where everything comes from. Because with two percent Irish it didn't really give 
me anything very descriptive. It just said, you have two percent. I was ok, that's 
cool. (James – Genealogy Group) 
 
If they gave you more information than that would be different… It'd be nice to 
have some type of direction. It's like, you know, now that you got your results, 
these are some of the options that would have been nice than here's your DNA 
results. (Tracy – Genealogy Group) 
 
So just maybe more of an explanation of each of the results. I guess just more 
detail about not, not just the research but more detail about the actual result itself 
and what that means. (Ian – Sequencing.com Health Group) 
 
5.5.2 Usability, Lack of Information, and Consumers’ Knowledge   
Usability is important because, without usability, no amount of utility can achieve 
the goal of producing a useful experience. Thus, one could argue without usability, utility 
cannot be achieved, and therefore the product or service can never be useful. In the 
course of the research, it was found that the participants were divided on the usability of 
the results they received.  A small subset of the participants stated the results were 
usable. However, two out of the three still stated they would have liked more 
information, as discussed next. 
Yes, I did. They were both really the format that they came in was really easy to 
understand. I was just like a chart and then the left of everything right beside it. 
(Vanessa – Genealogy Group) 
 
Yeah. Yeah, it was, it was clear. I mean, it's stated clearly. Yeah, it was clear. 




I remember thinking that they were simple which was good in terms of 
understanding, you know, it's kind of more like a yes or no, or here's the simple 
way to understand this specific kind of results. (Alex – Sequencing.com Health 
Group) 
 
Yeah, it gives me confidence, but you also have to interpret it with caution in 
general. So I would definitely want to take any results or anything that I find out to 
a geneticist and confirm… because I would just need an expert or professional 
opinion, to kind of solidify some of the things. (Sandy – Sequencing.com Health 
Group) 
 
Despite the three participants who said the results were usable, seventeen of the 
participants stated they needed or wanted more information or additional help.  Some 
participants also outright stated that they had a difficult time using the results, which 
was often based on their knowledge about the complex science behind DTCG testing. 
Of the participants, Sarah articulated this with the most frustration. Sarah is a 
Gen Xer with some college education who did not study science and does not work in 
science.  She was interested in learning more about history, but struggled to understand 
all of the results she was presented with. 
Even once I got my results, the information is still a little. A little thing on their 
website. And I don't know how to read that gene lane. They gave me a gene 
lane. So they are not very helpful with that, because you know they're kind of a 
smaller company. It's a little hard for me to understand some of the stuff because 
I'm not that savvy on you know the DNA. I could just read the top of the page and 
understand what that says. But then they give you like it rumoring and these 
colors and numbers. I don't understand that at all. So, some of it is good useful 
information and some of it is absolutely like why did they even give us that if they 
are not going to tell us how to read it. (Sarah – Genealogy Group) 
 
Other participants were less frustrated when speaking of the results, but still 
called clear attention to the fact that they did not understand many aspects of the 
results. 
What does an x match? Meaning what is the longest block. I don't understand 
any of that. So they need to put things in layman's terms would be a little bit more 
helpful if they go a little bit of way just to show what this means and how this 
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matches up on maybe more inclined to reach out. But I don't know what it 
means.. it's a lot of disconnects for me. (Tracy – Genealogy Group) 
 
Yeah, I think they [genealogy results] make sense. I mean the ones that don't 
make sense are the 23andMe medical reports… there's just more information… 
I've had friends who've taken that code to like nutritionists and other types of 
healthcare professionals who can actually break it down even more. (Don – 
Genealogy Group) 
 
Yeah, videos would because I went to YouTube and look them up myself. So 
maybe it's the website integrated more results that people put on me or 
something like. That would be cool. On the actual website. I mean they do a little 
bit. I think but not as much as they could. And I think that would really interesting 
because like I said, I immediately wanted to YouTube typed in reaction videos to, 
you know, and videos where people are walking through the whole process, 
taking the test and everything. (Vanessa – Genealogy Group) 
 
Well if there's somebody that you could contact if you wanted any further 
information or questions or are something of that nature. (Ruth – Genealogy 
Group) 
 
Just a basic explanation when you know, when you're not living in the scientific 
world, you kind of need that background… To sit down with a really qualified 
person who could go through and sit there with you, explain things, and answer 
questions and so on, you know, so instead of using an app or a website or what 
not, you'd be dealing with qualified expert. (Brenda – Sequencing.com Health 
Group) 
 
I do need help deciphering the information and knowing if it is one that has 
enough information in it.” … If they had something that was specific to, you know, 
finding out more, that would be amazing.... In like more about how to read your 
genetic results, you know, what of these things mean if there was some way to 
actually contact somebody to speak with them. We're not educated in that aspect 
of it. (Robyn – Sequencing.com Health Group) 
 
5.5.3 Usefulness, Validation, and Applicability  
 Similar to the utility and usability findings, the participants were divided on 
usefulness. However, between the two groups, the genealogy group did find the tests to 
be more useful than the Sequencing.com Health Group. Participants in the genealogy 
group often made this determination based on concepts of identity and connectedness, 
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whereas the health group held this opinion based on genes validating a health condition 
or calling attention to a potential opportunity. 
When speaking of usefulness, Ruth articulated an interesting point related to the 
earlier concept of identity. For Ruth, who lacks an understanding of her Jewish history 
given the atrocities of the Holocaust, DTCG testing helped her to find a connection to 
her lost past. 
That's what these DNA tests and things can help with that from an emotional 
standpoint. They can help you feel connected and also give you connections that 
may have been lost if you want that. (Ruth – Genealogy Group)  
 
Some participants like Don echoed similar sentiments to Ruth, while others found 
the knowledge to be interesting and offer a baseline understanding in their quest to 
know more about themselves. 
I think I've got some good results out of that and it's pretty accurate after testing 
my kids. Made me feel better once I got my results. At first I was a little skeptical, 
I really was… I just hope that these results that I get from my next go round are 
as good as, ConnectMyDNA results, which I think they will be. So I'm just excited 
that my family and I are going to pursue a different avenue with a different 
company to where we can build the tree and have the opportunity to be able to 
connect each other. (Sarah – Genealogy Group) 
 
So I realized that my dad was Jewish and like for some reason I had it in my 
head that I was probably like Greek or Italian, but, and I think like part of me 
really wanted to know like where I was from in the world on my dad's side, like, 
like, region, and like if you're, if you're an Ashkenazi Jewish, it's like you're from 
anywhere in this giant area of eastern Europe and it's like not really like a 
nationality at all. So at first I was like disappointed in somewhat, but then I was 
happy because I actually knew Jewish people. So I felt like I was part of a 
community… I definitely excite, just to like have an answer and be like I belong to 
this subset of people. Kind of like a belonging or like a knowing your history. Like 
most people around you around me know at least vaguely but not specifically like 
we're from this place in Italy or where we're from, you know, eastern Russia. It's 
like not knowing at all, like what my dad's side was. (Don – Genealogy Group) 
 
You know, there are a couple things I think that we need a little bit more 
knowledge on, some of the genes where they really placed. But overall I really 
think it's amazing what they have done so far with it. To pinpoint a condition that 
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doctors had been having a hard time with me for 12 years trying to figure out 
what it is. So yeah, I really think that they should be using it a little bit more. 
(Robyn – Sequencing.com Health Group) 
 
This is something that would give me a lot of information on what I could use to 
help knowing if my genetics are affecting how my ability to lose weight… what 
we've been doing is because I've just had some major surgery. So for the 
physical therapy we've been instituting the short bursts and exercise. Yeah. (Erin 
– Sequencing.com Health Group) 
 
I have changed my diet and I've made tweaks with my diet and also increase my 
activity level and developed an exercise plan. (Brenda – Sequencing.com Health 
Group) 
 
Interestingly, among the participants who did not find it useful, the concepts of 
accuracy and/or applicability seemed to stand out as the cause for concern. The latter is 
interesting because, in the study, it was found that only two participants from the 
genealogy group made use of the social networking features within the DTCG websites 
to connect with other users, and only two participants out of the health group changed 
their health behaviors after getting the results. 
For the participants who felt the results were not useful, Tracy who is 
passionately trying to understand her past was the most skeptical, given the changing 
percentages of ethnicity she has experienced in the results over the past year. 
The funny thing is that when I first got the results back last year… and then I just 
used the test today because I got another email…. The numbers have changed 
and so now... I guess I don't think the test is accurate at all now because I have 
two different versions...  So that tells me I don't have any faith in this, in this DNA 
system anymore. It doesn't, it doesn't hold well if yield two different results in a 
years time. (Tracy – Genealogy Group) 
 
Other participants were less critical about the results themselves, but 
acknowledged that they are often not directly applicable at this time, or felt that they 




No, I mean that was like the first step, you know, is like paying the money, getting 
the results, like understanding that, getting familiar with the website, talking to 
other people and the next step of like talking to my friends, getting their contacts 
and then have the medical professionals. But I haven't done that yet. (Don – 
Genealogy Group) 
 
I think that for the average person who gets this task, they have access to a lot of 
data that they don't necessarily know how to interpret and I think if it came, it 
would be a lot more useful to someone who doesn't have the background if it 
came with like a primmer or like a, this is what these numbers mean in practical 
terms. Don't freak out. I have the experience of I'm trying to explain this to my 
father. I showed him some of my data because he was interested in looking at a 
few things and trying to. He jumped to conclusions or wanted to analyze data or 
draw conclusions from data in a way that was not meaningful when you clearly 
didn't understand what kind of conclusions could be drawn in terms of risk. And 
so I think an explanation of what the statistics mean and how meaningful it is on 
an individual as opposed to a population level is necessary, and could be done 
much better… As the field of genetics progress, if we're able to draw much 
stronger conclusions or meaningful conclusions from the data than we can now I 
can proceed doing so. (Sophia – Sequencing.com Health Group) 
 
I don't know if I would say directly useful, but I'm happy to have the information 
and I'm hoping it will be more useful as time goes on. (Claire – Sequencing.com 
Health Group) 
 
I want to meet with the doctors and, and make sure that I'm going in the right 
direction because I'm not a genetic specialist by any way, shape or form. And I 
do rely on their expertise in medical knowledge over mine. (Robyn – 
Sequencing.com Health Group) 
 
No, I don't think so... There's not really much I could do to help myself and I don't 
have anything bad going on at the moment. (Scott – Sequencing.com Health 
Group) 
 
I don't think there was anything that specifically like stood out to me that needed 
to be a behavior change. (Ian – Sequencing.com Health Group) 
 
No, cause I already, I already knew about that risk factor in my family, so I 
already take steps to avoid that. (Alex – Sequencing.com Health Group) 
 
Given the findings, the user experience of current platforms is called into 
question. While the desired utility of the DTCG consumers appears to be well defined, 
that is, to better understand their family history and/or health identity, the experience 
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today appears to fail in consistently delivering on that promise. The problem was found 
among both groups, however it does appear to be more widespread within the health 
group.  It is theorized the major stumbling issues are lack of information, consumer 
literacy and their ability to understand the information presented, and the applicability of 
the information.  
 
5.6 Genomic Literacy and Consumer Perceptions of Risk in the Bioeconomy  
Given the high levels of trust in DTCG tests, and user experience shortcomings 
that result from lack of consumer literacy, consumer safety also needs to be discussed. 
Social scientists have called attention to a number of risks associated with consumers 
exchanging their genomic data, or biocapital, with private DTCG companies, and the 
use of that data by companies (Hogarth and Melzer 2008). Consumer advocates have 
often stated that consumers lack sufficient genetic literacy regarding genomics and 
information technology, and subsequently opt into contracts that allow the companies 
unprecedented control over the use of their biocapital because of how the consent 
process is structured.  
The reason for this is because the purchase of a DTCG test is structured to be 
relatively frictionless. A consumer typically goes to a website and orders the test with a 
few clicks like almost any other e-commerce experience. While efficient, some believe it 
is also dangerous because consumers are opting into a contract that often has large 
ramifications related to their personal DNA and what the DTCG companies may or may 
not be able to do with that data (Phillips and Charbonneau 2015). The concern is 
grounded in the way the legal terms are delivered.  The legal terms are often able to be 
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found via a link from the homepage and are also typically displayed in some format 
during the purchasing process.  However, the concern is the way these terms are 
shown, and the complexity of the terms themselves. Most of these legal agreements 
that DTCG consumers opt into are in the format of a wrap contract. Wrap contracts, 
which are often called shrink wrap contracts because they are often inconspicuously 
packaged with products, can be defined as a unilaterally imposed set of terms which the 
seller states are legally binding, on use of the product (Kim, 2013).  
As e-commerce increased, this idea was expanded into web-wrap, click-wrap, or 
browse-wrap license agreements that function in a similar way, however, they are 
possibly even more inconspicuous since they sometimes only required a scroll of the 
mouse or a click of a button to easily agree to the terms of the contract.  Of the three 
methods, the clickwrap and browsewrap are the most commonly used. Clickwrap 
contracts require that a user scrolls through terms and click "I Agree" at the end. 
Browsewrap contracts typically don’t even require the user to scroll through the terms, 
and instead display a hyperlink to the agreement, thereby making it possibly for a user 
to click "I Agree" without ever viewing the terms. With that in mind, a 2015 study 
reviewed the contracts of 248 DTCG tests and found that they are often long and 
complex, and typically make use of the common implementations of either clickwrap or 
browsewap contracts (Phillips and Charbonneau 2015). This raises the question, do 
consumers of DTCG tests even read the contracts, and if so, are they clear on what 
they are consenting to? 
The question of what a consumer is consenting to is steeped in medical and legal 
issues. From a classical medical perspective, the doctrine of informed consent is a 
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cornerstone of ethical practice in research that is built on the promise of beneficence in 
a clinical relationship (Spector-Bagdady 2015). It is something that both academic and 
clinical researchers take very seriously given the past history of harm, like in the 
Tuskegee Syphilis and the Milgram experiment. Traditionally, the process of informed 
consent requires that subjects are provided sufficient information about the research to 
be able to make an informed decision as to whether or not they wish to voluntarily 
participate in the research. However, in the case of DTCG testing, this process is 
substantially less rigorous than traditional academic standards given the way the tests 
are purchased. Furthermore, the future of the industry is full or potential, but still not well 
defined.  Since the long-term goal of many of the DTCG companies is to monetize the 
data they are collecting, and because most of the applications for that data are yet to be 
determined, it is nearly impossible to draft a contract that is able to accommodate all 
potential uses cases for the data in contracts today. To handle this issue, many of the 
contracts reviewed in the study include a unilateral change of terms clause which often 
allows companies to change their terms without direct notice to the consumer. Consent 
to clauses of this nature are generally realized through the continued use of the website 
or service, even if the updated terms are never again encountered by the user in the 
course of that use 
Thus, the terms governing how a consumer’s DNA can be used may change 
over time, and the consumer may continually opt into the updated terms without even 
realizing it simply through continued use of the service (Phillips and Charbonneau 
2015).  The result of this could mean that the consumers’ data can be used for 
purposes they never understood, nor ever could anticipate based on the terms of the 
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contract they initially opted into, such as their personal biobanked data being sold to any 
unforeseen third party for uses that they never anticipated, or comfortable with. 
However, the consumer would no longer have control over their own data. 
 
5.6.1 Consumer’s Trust in Exchanging Their Biocapital  
To gauge consumers’ perceptions about exchanging their biocapital for results, 
study participants were probed to gain a sense of the trust they held in the companies 
and the potential harm of the data being in the hands of the companies. They were 
asked specifically if they trusted the companies and why, and about the data being 
stored on webservers and the potential harm they see in their data ever being 
compromised. These questions built on the previous questions which probed the 
participants to gain a sense of their trust in the scientific claims. Similar to those 
findings, the majority of participants were found to trust the companies enough to 
exchange their data with them to get the results they wanted. In some cases, the 
participants were hesitant but felt they had no other option if they wanted to get the 
knowledge they hoped to get based on the scientific claims. 
Of the participants, Vanessa, a young millennial, was the most trusting of the 
companies with her data. While she acknowledged that cyber security was an issue, 
she was not that concerned. 
I've thought about that. I'm not really like a conspiracy theorist or anything. So 
yeah, I do trust them. I don’t think they are going to do anything with that, that I 
wouldn't want them to do… Yeah, I guess it does because hacking is so 
common, but it's a very minor concern. (Vanessa – Genealogy Group) 
 
Other participants were less overt in their trust, but also similarly not concerned 
about security.   
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I just, I've never heard of anything negative happening, you know, people say, 
oh, what if they like stop you from getting healthcare in the future and um, like 
that's like the only concern, but I'm just like, I don't think that's going to happen in 
my lifetime and you know, if it does the world is that messed up, that's what 
happening by then. There's probably a lot of other bad stuff too. And like I'm not 
going to be worried about that. (Don – Genealogy Group) 
 
That's just the risk that we take, given the world that we live in today. So, I try not 
to worry too much about it. Just hope the information isn't misconstrued in any 
way or use for anything other than what was supposed to be used for. (Sarah – 
Genealogy Group) 
 
Yeah, um, yeah, I mean, as much as I guess I would trust, you know, um, 
Experian, Equifax and whatever else with my social security number, you know, 
or banks... If somebody knew this information, I don't think it would, you know, I 
don't think there's any value to a hacker or a dark web, somebody fishing on the 
dark web. I don't think there's any kind of a value to this, so to speak. (Tom – 
Genealogy Group) 
 
As much as I can, I try to have the, I assume the best in people and, and 
hopefully it's safe. I sort of like the consent form said, do you know anyone using 
the Internet takes a certain amount of risk and the seems worthwhile. (Claire – 
Sequencing.com Health Group) 
 
I'm fairly confident that it won't get out. However, if it were critically important to 
me, if I believed truly that it was extraordinarily important to that data never get 
out, I wouldn't trust them enough to have it. If I thought they were going to 
release it to everyone with my name, I probably wouldn't have given it to them. I 
have a reasonable level of confidence that they will not publicly link it to my 
name, but not absolute confidence that it won't get attached to my name outside 
of them… I do but I don't I think the risk is that large. But that's more than, I don't 
think the information is that meaningful and I don't think, you know, it's a lot of 
data so it's not something that someone is going to. It would be very hard to leak 
30 gigabytes genome for every person in your database and no one is going to 
care enough to collect that much data. (Sophia – Sequencing.com Health Group) 
 
“I was looking through privacy policies and things and when they send stuff back 
to you, your names aren't used on the files... I'm just not worried about it the way 
it is and I would hope that they would do more good with it then bad. I know that 
sounds horrible, but it's just like, well, it's not my social security number.” (Robyn 
– Sequencing.com Health Group) 
 
Yeah. I trust those companies that have it. I don't think they are going to sell it or 
use it in and identifying way… I think they're taking as many steps as they can, 
but I also am not concerned that somebody is going to hack in and steal all of the 
genetics data per se. I mean, I don't know what would be the goal of somebody 
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to do that. So I guess I'm not super concerned. (Alex – Sequencing.com Health 
Group) 
 
I don't think it's significant because I don't know. It's just life. It's not my address 
or my social security number. I don't feel like I could have a monetary loss on this 
one so I can affect my health. I mean I don't understand how my DNA being in 
the hands of somebody is going to hurt me. (Scott – Sequencing.com Health 
Group) 
 
Personally I think my DNA data is anything too much to get excited about. (Erin – 
Sequencing.com Health Group) 
 
I guess I would have to. There's not really an option to not put otherwise I 
wouldn't have the data that I do have without it. (Ian – Sequencing.com Health 
Group) 
 
5.6.2 Consumers’ Perceptions of Ownership and Fair Use of Biocapital 
In speaking with the participants, about half indicated that they looked at legal 
policies of the DTCG testing companies. However, of that group, very few read it in any 
great detail, and so the majority seemed to lack a sufficient amount of literacy to speak 
about the ramifications of the contract. Given this and building on previous research 
concerning the unilateral change of terms clauses that show up in the contracts, the 
consumers were probed further to get a greater sense of who they feel should own the 
data, and what constitutes fair use of it given the nature of the contracts they have 
opted into.   
The majority of participants believed they should own their biocapital however, 
but some of them also acknowledged that they may have granted the companies rights 
to it as a result of taking the test. Of those in the latter group, they somewhat 
begrudgingly acknowledged the reality of the exchange, but typically wished they still 
had some right to own the data.  Over the nineteen participants, only two felt the 
companies should own the data.  
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 Surprisingly, despite the overwhelming interest of the participants to own their 
own data, they were also quite comfortable with the data being used for research if used 
appropriately.  However, the concept of what was appropriate, or fair use, was most 
often based on them granting consent for the data, which paradoxically, many did not 
realize they already did. Other factors that contributed to the concept of fair use for the 
participants were grounded in the purpose of the research. Most participants wanted the 
research to be for good use, such as academic or non-profit research but were more 
concerned if it was revenue generating.   
By contrast to their comfort with sharing data, most participants had significantly 
stronger opinions regarding ownership and fair use. James, a confident-talking 
millennial with an undergraduate education and full-time employment with earnings that 
put him in the middle class, broadly summarized the sentiments of the group. He stated 
that he wished to own the data but acknowledged that he signed away his rights. 
However, he did feel he should be made aware if the data was going to be used. 
I feel like I should own that data, but since I did sign the privacy agreement with 
them, they should have the data but not for like to broadcast to the world 
anything, but just to have in their database… I feel like they should contact me 
first because it's my data. I mean if they're going to use my stuff or research or 
they should let me at least give me the courtesy to know that they're going to do 
it and let me agree to information everywhere. I feel like that's something you got 
to have consent for. (James – Genealogy Group) 
 
Most of the other participants echoed James in the sense that they wished to 
own the data; however, they acknowledged that a business transaction had occurred, 
and just hoped the data was used appropriately.  
I would say me, but I'm not sure who does legally…. Like I don't know if in the 
fine print it signed off my DNA to them as, as the data to them as owners, but if 
they are assuming that ownership, I would want a more explicit and clear right to 
give that to them… I'd be fine with that. I would just hope that they would ask 
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permission, but I'd be more than happy for them to use it if it could help other 
people or help research. (Toby – Genealogy Group) 
 
I think us as the consumer should, however we're releasing our information to 
these people so… I'm ok with research that's the way that we learn. So I'm OK 
with research. I like to do research. That's how we learn new things in technology 
and genealogy and all that good stuff. We're in the world now where that 
information is so readily available why not take advantage of it now that we have 
the source.  (Sarah – Genealogy Group) 
 
I think it's yours, I think it should be the person who's it is and if they want it 
destroyed, you know, or taken out of the database then they should have that 
right to do that… If it's for academic or nonprofit research, I have no problem with 
it. If it's going to incorporate like a for-profit corporation or some kind of entity like 
that than I would have been. I wouldn't really be OK with that. Like if they're 
selling to, you know, some list. So you get on some list for mailings and whatever 
else or email then that, that kind of that's not good or I think that kind of sucks. 
(Tom – Genealogy Group) 
 
Well, I've given it to them. So my giving them my information, we both own it. 
They own it because they have it and I own it because it's my information… I 
wouldn't mind if my, you know, like I have seventeen percent of Irish blood in me 
or whatever. I wouldn't mind if that was used for a research because I don't know 
that they would be disclosing each person's name individually. If it just the 
background facts of to add to their research. (Ruth – Genealogy Group) 
 
I mean it's like my information, but they're the ones who are finding it out for me. 
Like without them, I would never know what it is… So it's like, I mean, I think it's 
both, I guess… Like I said, like I wouldn't know anything about me if they didn't 
research other people's genes. (Don – Genealogy Group) 
 
I think that I should own the data about my health information and they should 
own the proprietary technology in terms of how they got the information and how 
they obtained it. (Amy – Genealogy Group) 
 
I personally, I think I should own it. Because it's mine. It's me... I think we need to 
be able to use stuff like that for research because if we don't, how are we ever 
going to get ahead? (Erin – Sequencing.com Health Group) 
 
Well me, but you know.... it's my health data. It's my kind of who I am… You 
know I'm actually OK with that. I go with the assumption that my personal data is 
kept confidential. That I would be like Jane Doe or 1591 or whatever. (Brenda – 




Well, I should own it.... It isn't mine. It's about me… If you're doing some research 
then I don't care. Let me sign a consent in a waiver and you know, all that good 
stuff. (Sandy – Sequencing.com Health Group) 
 
I think ultimately the individual owns their own genetic data, whether or not that's 
done through, like if you pay for somebody to test you or if you sign up for 
research, I think ultimately you own your own genetic data… Yeah, I think as 
long as I knew about it that would be fine, and it was anonymized. (Alex – 
Sequencing.com Health Group) 
 
I think, I guess I ultimately should own the data, but I guess there's a play a part 
in each one of those that does own the data. (Ian – Sequencing.com Health 
Group) 
 
I think they can own the right to profit from distributing that data. I don't think they 
own the information itself or should be allowed to own the information itself. 
(Sophia – Sequencing.com Health Group) 
 
It should be mine, but I have shared it with a company… As long as they talk to 
you and say, hey, we want to do this or not going to expose your name or 
anything else like that, then I would be OK with them using it or whatever we 
needed to. (Robyn – Sequencing.com Health Group) 
 
Based on the findings, the research theorizes that that previous literature is 
correct in its assessment of DTCG consumers. They do appear to lack sufficient literacy 
to make completely informed decisions when purchasing a DTCG test, and as a result, 
do not have a complete understanding of what they have opted into. Likewise, it is being 
suggested that the process of consent is made more explicit and that consumers are 
given more control over the use of their data. Control over the data may include 
restricting it from being used for research or sold, as well as giving them the ability to 
delete the data should they wish to no longer have it part of the database. Furthermore, 
since customers wish to own their own data, a model should be considered where 
consumers do own their data, but essentially can license it to the DTCG companies in 
exchange for the ability to use it as part of research. This would support both parties 
assuming the role of producers within the bioeconomy.  
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CHAPTER 6 
CONTRIBUTION AND REFLECTION 
The thesis project involved exploratory research to understand the beliefs, 
attitudes, and behaviors of consumers who have used DTCG genealogy and health 
tests. Exploratory research was used because it is “useful for developing original 
product and service ideas or finding new applications for existing and emerging 
technologies” (Squires 2002, 104). To accomplish this, ethnographic research was 
conducted through the lens of design anthropology. Consumers of both types of types 
of DTCG tests participated in qualitative research. The research sought to uncover new 
dimensions about the forms of sociality that influenced their decisions making to adopt 
DTCG tests, and to learn more about their everyday practice with the tests, and the 
meanings they ascribe to them. (Wasson, 2000; Wasson, 2016). 
The objective was to understand how consumers became knowledgeable of the 
tests, why they chose to adopt them, and what are their perceptions of the tests after 
taking them. The findings were qualitatively analyzed using thematic analysis to 
produce rich ethnographic insights. These insights were then mapped to the Diffusion of 
Innovations (DOI) theory to gain a sense of factors influencing the diffusion process 
from a sociocultural perspective. 
The analysis supplemented the DOI with extensions to the original DOI as well 
as other theories. Specifically, disruptive innovation theory was employed because 
innovations such as DTCG testing can result in competence-destroying discontinuities 
that require new skills, abilities, and knowledge in the process of delivering a new 
product class (Christensen 1997). Likewise, the dynamics of diffusion and adoption for 
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these types of innovations are critical to understand because as Geoffrey Moore’s 
Crossing the Chasm model theorizes, specific steps must be taken on the part of a 
business to overcome the chasm, which is a hurdle in achieving critical mass adoption 
of new disruptive innovations. Two of Moore’s techniques that this research focused on 
were defining a target market and whole product concept. 
Defining a target market involves understanding and focusing on a specific 
customer segment, their needs or wants, and the sociality that occurs between 
members of that segment. Defining the whole product concept involves fully thinking 
through your customer's problems and potential solutions (Moore 2014). Likewise, 
Sequencing.com must make strategic product decisions that can satisfy the correct 
customer segment at the correct time along the adoption curve. However, 
accomplishing this is challenging as they need to correctly make critical product 
decisions under conditions of scarce resources (Jantunen, et al. 2011). Thus, a series 
of tradeoffs often need to be made thereby creating a business challenge that is difficult 
to sustainably navigate.  
The goal of this research was, therefore, to address this business challenge by 
using design anthropology methods to produce actionable ethnographically informed 
insights that Sequencing.com can use to define their target market and create a whole 
product concept that is mutually beneficial to their business model, as well the 




6.1 Summary of Findings 
The following table details a summary of the key findings based on the themes 
uncovered in the course of the research. 
Table 1: Table of Summary Findings 
Socialization and 
Diffusion 
Advertising and social influence, particularly of kin, are both 
effective for producing knowledge of DTCG testing. To that end, 
both have assisted in the diffusion of DTCG testing to date. 
However, there appears to be a great opportunity to improve the 
rate of diffusion. It is suggested that both methods be used in 
combination. Specifically, advertising ought to be directed to the 
kin of previous adopters. 
Trust and 
Adoption 
Consumers have demonstrated that they derive trust in DTCG 
tests in a number of ways form scientific claims, social influence, 
and promises of future-oriented knowledge. However, previous 
research has also shown that there are reliability issues with some 
testing given methods, data sets, or the science used for 
multigenic prediction. Given this, it would be advised from an 
ethical perspective to call attention to shortcomings in methods, 
datasets, and or scientific claims, and make it easy for consumers 





Learning more about the concepts of identity appears to be one of 
the most motivating factors for choosing to adopt along with the 
social influence of kin. Likewise, appealing to this desire is likely 
an effective strategy when targeting consumers. However, as 
noted with the trust concept, this ought to be done in such a way 
that is not based on faulty assumptions or overstated promises. 





Sharing can represent an action in time, but also a larger symbolic 
concept of passing into the biosocial. It is spoken of very fondly by 
consumers, even if they don’t frame it as a rite of passage 
specifically. Catering to this need may help satisfy this ritualistic 
need, while at the same time increasing the opportunity to create 
new instances of social influence among kin to drive the next 
round of adoption. 
Towards a User 
Centered Design 
The user experience of DTCG is still lacking. Specifically, it was 
found that a lack of information, consumer ability to understand 
the information presented, and the ability to apply the information 
appears to be the cause. To address those shortcomings, more 
flexibility should be granted to the user to accommodate the needs 
of varying degrees of proficiency. The focus ought to be on the 
usability of the results, as that appears to be negatively impacting 




Risk and Future 
Opportunities  
There is an opportunity to empower the exchange of biocapital 
between DTCG companies and consumers, that does not have to 
harm the companies but can protect consumers than they 
currently are.  This opportunity should be leveraged, by providing 
more clarity and control to consumers who are not trained in 
genetics since they need assistance navigating the DTCG 
industry. To accomplish this, the consent process should be 
simplified, and the consumer should be given more control over 
their biocapital. Allowing the consumers also to own and license 
the data is a significant opportunity to ethically flatten the playing 
field in the bioeconomy and do well by doing good. 
 
6.2 Critical Insights 
The findings of the research illuminated six critical insights related to DTCG 
health testing which Sequencing.com needs should be aware of when defining their 
target market, whole product concept, and strategic intent. The insights are: 
1. DTCG genealogy and health tests appear to be at different points on the 
adoption curve, which is producing some differences between the genealogy 
and health group consumers. 
2. Social influence plays an important role in influencing the diffusion and 
adoption of DTCG tests, and particularly, the influence that comes as a result 
of kin. 
3. Consumers base their sense of trust regarding the science claims on either a 
belief in science, others, or the promissory language of the marketing efforts 
of DTCG companies but appear to lack the ability to validate the claims.  
4. The test results consumers receive generally leave them wanting more 
information or additional support. This effect of this appears to be lessened 
for the genealogy group, however for the health group, the perceived 
usefulness of the test results is quite low. The genealogy group does appear 
somewhat satisfied to learn anything about their family history, though most 
participants still wanted more information. However, the health group 
generally finds the data to be more of a novelty that is not ready for 
application yet.  
5. Consumers are far less concerned about sharing their DNA with DTCG 
companies than is often discussed in the literature, however, they also want 
more control over their biocapital, such as the ability to delete it from the 
database or delete it.  
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6. Sharing the data with other people, such as kin appears to be compulsory in 
the sense of a rite of passage. This applies to the health and genealogy 
group, and the genealogy group often takes this step further and also 
frequently shares the data with friends, coworkers, or even the public internet. 
Those insights translate into a few broad concepts that need to be considered 
when crafting specific product management recommendations and business strategies.  
 
6.2.1 Point on the Adoption Curve 
It appears that that DTCG genealogical testing was further along the adoption 
curve than health testing. This is supported by estimated sales figures, previous 
research, and the qualitative ethnographic research conducted as part of this study. 
Sales estimates put genealogical tests significant ahead of health testing with the 
leading genealogy company, Ancestry, representing about 62% of the total DTCG 
market. (Forbes 2017). Given this, the needs and wants of the customers appear to be 
different, as do their levels of literacy. Likewise, each group needs to be approached 
differently.  
 
6.2.2 The Importance of Social Influence 
Social influence was the most significant factor influencing the diffusion and 
adoption of DTCG tests, but interestingly, it also influenced consumer’s perceptions 
about the test experience. Specifically, it was shown that influence of kin had the most 
profound effect for motivating users to take the test. The sociality of kinship contributed 
to this, as well as the desire to learn more about one’s genomic makeup, which is a 
factor of kin. The latter was pertinent to genealogical and health knowledge, and thus 
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applied to both groups. The importance of social influence mirrored previous findings 
related to the DOI and TAM. 
 
6.2.3 Customers Lack Literacy, Respect Them   
Customers today lack a sufficient amount of literacy to fully understand the 
process DTCG testing process. This applies to how they derive their trust in the 
science, how they interrupt the results, their understanding of the contracts and what 
they consent to, and the importance of their data being stored safely. As a result of this, 
the consumer should be respected; and care should be taken to protect them because 
to some degree, the current adopter group is not fully able to do this for themselves.   
 
6.2.4 Extra Care Needs to be Given to Design 
In the Technology Acceptance Model (TAM) usefulness is a strong predictor of 
continued adoption. Unfortunately, the majority of participants stated that the tests were 
not useful, with many citing concerns about usability that contribute to usefulness. While 
this is not unexpected given that disruptive innovations which involve competence-
destroying discontinuities like DTCG testing require new forms of knowledge from 
consumers, it still creates unfavorable perceptions among the users. Given their low 
level of literacy, and the varying abilities, more effort needs to be made to increase the 
usability of the tests and provide greater flexibility to the users to enhance utility. These 




6.2.5 Blue Ocean Opportunities  
 It was found that the participants are not concerned with their biocapital being 
used for research. However, they do wish that they would own the data. Given their 
literacy, and in the spirit of being fair to the consumer, there is an opportunity to create a 
model that gives the consumer more control over their own data, potentially, even 
allowing them to own their data, and license it for use.  
Furthermore, given that sharing results with kin and others was so compulsory, 
there is an opportunity to leverage this ritual to satisfy the needs of the consumers, but 
to also create a feedback loop that furthers the diffusion and adoption of DTCG testing 
to create a hurricane within the concept of Crossing the Chasm. 
 
6.3 Adoption Model for the Current DTCG Health Test Adopters  
 Based on the research, the most critical factor that mediated the experience was 
social influence, and in particular, kinship. In general, social influence played a 
significant role in diffusing DTCG testing, influencing decisions to adopt, and 
perceptions of the experience once a test was taken. Particularly, though, kinship acted 
as the largest driving force given its relationship to sociality, trust, and identity.  
Thus, kinship ought to be leveraged when defining the target market and 
deciding on features to create a whole product concept, however, the power of targeting 
users who will be influenced by kinship should not be abused. This group is very 
receptive, but also, as the research demonstrated, many consumers in the early days of 
adoption lack a sufficient degree of literacy to be able to understand what they are 
opting into and getting out of the test. Therefore, while kinship ought to be used to 
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define the target market, consumers should also be made fully aware of what they can 
expect to learn about themselves and their kin by taking a DTCG test. 
 
Figure 18: Adoption Model for the Current DTCG Health Test Adopters 
 
6.4 Contributions to Client 
Based on the insights learned from the qualitative ethnographic research and 
analysis process, as well as my user experience, software product management, and 
business strategy experience, the following recommendations are suggested. 
 
6.4.1 Defining a Target Market 
Based on the insights of this study, it is recommended that Sequencing.com’s 
immediate target market be defined as consumers who are related to previous users. 
This will support the diffusion process, as well as the decision to adopt and also help to 
positively influence the perception of the experience.  
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Furthermore, given the lack of applicability participants reported, it is also being 
recommended that Sequencing.com focus on a subset of consumers. That subset 
should involve consumers who are who interested in tests that can accurately be 
reported on, appreciating that most DTCG consumers are using data they get from 
ancestry-based testing services, which means they are not whole genome sequences 
and thus many results for multigenic conditions cannot be reported on accurately.   
Likewise, based on that fact, and the recommendations of Geoffrey Moore in 
Crossing the Chasm, it is recommended to focus on consumers with problems that can 
concretely be addressed in the current state of DTCG health testing. This will produce 
the greatest sense of usefulness, which according to TAM can lead the users to 
recommend the product, and thus support diffusion and adoption. 
 
6.4.2 Defining the Whole Product Concept 
Based on the insights of this study, it is recommended that an immediate effort 
should be placed on building mechanism for kin to recommend the product or specific 
apps to their family in a referral-like system.   
Related to that, clear and easy mechanisms ought to be made to allow users to 
share their results with other people, through various modalities to satisfy their desire to 
share, but also to enable the hurricane effect to amplify diffusion and adoption. 
The results consumers are provided should also be made easier to understand, 
but enhanced functionality also needs to be built in to offer more flexibility and access to 
more elaborate data on request. Many of the users made positive comments about 
Promethease which links to SNPedia, which allowed them to explore as little or as much 
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as they wished, but in either case, it provided greater flexibility to meet the varying 
degrees of needs. 
Building on the shortcomings in results, an emphasis ought to be made to make 
the results directly actionable, as the health participants overwhelmingly discussed this 
as a shortcoming. Concepts of nudging from behavioral economics can likely be 
leveraged to increase the likelihood of application and continued use. 
Given consumers’ willingness to share their biocapital for use in research, but 
their desire to own it, Sequencing.com ought to consider putting their Altruist Center 
functionality on a blockchain that allows users to contribute their DNA to help science, in 
exchange for cryptocurrency that they can be exchanged for value within the platform to 
buy more apps. 
Finally, given the fact that consumers often make use of multiple testing services 
and or analysis services, Sequencing.com may want to consider offering test kits so that 
participants can start the process with Sequencing.com. Furthermore, it should increase 
the number and depth of integrations with app providers. To the degree that 
Sequencing.com can keep the user within one ecosystem, instead of requiring 
consumers to go elsewhere for extra services, will enhance the stickiness factor of the 
product. 
 
6.4.3 Establishing a Strategic Intent 
When speaking with participants, it was clear that today they lack a single source 
of truth for genomics. Most participants have had their DNA tested by multiple DTCG 
companies, and then they have independently analyzed that data at a variety of 
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websites like Sequencing.com, Promethease, DNA Land, GED Match, and others.  
Given this gap in the marketspace and based on the fact that Sequencing.com is 
already an established app market, it is suggested that Sequencing.com stretches to 
become the hub of consumers' genetic life. This does not imply that this would be done 
overnight, but it is meant to be a long-term goal in the spirit of how "Komatsu set out to 
encircle Caterpillar, Canon sought to beat Xerox, and Honda strove to become a 
second Ford-an automotive pioneer" (Hamel and Prahalad 2005, para. 13). 
 
6.5 Directions for Further Research 
The research demonstrated there are differences between the two groups. 
However, the sample size was not large enough to determine what exactly were the 
differences and why they occurred. It is theorized they may be a representation of the 
characteristics of different adopter groups based on the respective points along on the 
adoption curve that genealogical and health tests are, or it may be a result of the 
different types of products attracting different customers. Either way, more research 
should be conducted to determine how and why the groups are different, and if 
possible, those characteristics should be mapped to the DOI adoption curve to help 
better define the target market and whole product concept. 
Building on that, the research may also wish to observe consumers in their 
natural environment instead of remotely to gain a greater sense of the user, and their 
context of use.  In the current remote interviews and observations, only audio and a 
screen capture of users using Sequencing.com was recorded, and thus there is still a 
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significant opportunity to learn more about the users, and how their use relates to 
others, especially kin in the case of users who live with family. 
Furthermore, research ought to be conducted with non-users.  Developing an 
understanding of why consumers have not chosen to adopt either type of test would 




As a result of this research, I learned that conducting ethnographic research is by 
no means a straight line. From the outset of the project to writing this reflection, I have 
been consistently amazed by how frequently things deviated from the ideal plan. In 
retrospect, I suppose that should not be surprising, after all, humans are a complex 
animal. But none the less, it was eye-opening. 
It also has become very clear to me that the analysis of rich data is a complex 
and nuanced process that is more than theory and methods. It, of course, involves 
those. However, it also involves the researcher and everything they bring to the table as 
a person that is a product of their own culture. From the topic we select, the research 
questions we think to ask, the scripts we use to guide our interviews, to the way we 
interpret the data; it is all subjective. As such, I think it is worth noting that we are as 
much part of the process, as we are part of the outcome.  
To that end, my anthropology training certainty contributed to me being able to 
carry out this project, for it is in the UNT program that I learned of the methods and 
theories that I employed in the project. Methods that allowed me to uncover data that I 
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may not have been able to otherwise, and theories that allowed me to situate it in a 
larger sociocultural context.  However, it should also be noted that my previous biology 
and business education also came into play as a subjective researcher, which is why 
they are so present. And why should I not invoke those other disciplines and use them 
as additional lens to factor into the ethnographic process? After all, they are part of my 
worldview, and maybe more importantly, they are also a part of our social fabric and 
cultural identity as a group of people living in a world that offers products like direct-to-
consumer genomics (DTCG). 
So what did anthropology add to the outcome? For me, the most important thing 
was the acceptance of other worldviews, be they of another group of people such as the 
participants in this study; or another discipline such as sociology or information systems. 
Of course, it also overtly contributed methods and theory, but what is more important to 
me, was its holistic nature for understanding and doing. Much like the DA design 
anthropology model, it allowed me to be reflexive yet prescriptive, and at the same time, 
openly accepting of that. From the outset, the goal was to understand the past, to 





This study set out to achieve a few goals. First and foremost, as an academic 
exercise, it sought to develop me as a design anthropologist by applying the knowledge 
I learned at the University of North Texas to a real-world project.  
The project I selected was to gain an understanding of how the DTCG market is 
maturing. I attempted to do this by developing an understanding of why DTCG health 
tests are adopted, how and why they diffuse, and what needs to be done to ensure we 
design the DTCG experience in a way that is beneficial, useful, and respectful of 
consumers. 
To accomplish this, I conducted ethnographic research to understand the 
differences between consumers who have previously used DTCG genealogical tests, 
and those who have used DTCG health tests. I made use of design anthropology 
methods to produce actionable ethnographically informed insights that could benefit my 
client, Sequencing.com. 
These insights were intended to help Sequencing.com define their target market 
and create a whole product concept that is mutually beneficial to their business model, 
as well the consumers that adopt the innovation. I also suggested a conceptual, 
strategic intent: to be the hub of consumers' genetic life. 
Finally, I wanted to apply design anthropology to product management and 
business strategy. Design anthropology, though often discussed in the context of user 
experience design, is currently underrepresented when discussing these other 
disciplines, yet it represents an ideal complement to those disciplines. Likewise, I plan 
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explore the intersection in further publications, as I believe it is an area of scholarship 
that is lacking and offers tremendous potential to place the human back at the center of 
the equation of technology management and business strategy. 
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IRB APPROVED SEMI-STRUCTURED INTERVIEW GUIDE GENEALOGY GROUP
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You will be asked to participate in a genealogy genomics interview and an 
observation session that will take approximately 30 minutes to 1 hour. The interview will 
be conducted via a conference voice line. During the interview, we will ask for 
permission to record the audio. The audio will be used to create accounts of your 
expectations and experiences. Your identity will be kept completely confidential. 
Pseudonyms will be created and used for all individuals who participate in this research. 
Signed consent forms will be required to be signed prior to starting the research. The 
signed consent forms and analysis documents will be stored in separate locations. 
Video, audio, and/or still photos will be stored in a locked cabinet after it is recorded. 
Computer records will be password protected. The confidentiality of your individual 
information will be maintained in any publications or presentations regarding this study. 
1. How did you first learn about the concept of genetic tests for genealogy? 
2. What did you think when you first learned about it?  
3. Can you tell me about the specific genetic genealogy tests you have taken in the 
past? 
4. How did you hear about that test(s)? 
5. What was your reaction when you learned about the test(s)? 
6. What made you interested in taking the test(s)?   
1. Did you have any specific goals or outcomes you wanted to achieve? 
7. Did you trust what you heard about the tests, be it verbally, in print, online, etc? 
8. Did you review the company's website? What did you think? 
9. Did you read any of the privacy policies or terms of use? If yes, what were your 
thoughts? 
10. What did you expect to learn the test? Learn about ethnicity or relatives? 
11. What was your reaction to the ethnicity analysis? 
12. How did you feel after the test? 
13. Did it help you better understand yourself and your personal identity in anyway? 
14. Did you use any of the social networking features to interact with relatives 
(distant or close)? 
15. Did you contact any of the matches, and if yes, what were your interactions like? 
16. How did it feel to learn of potentially new relatives? 
127 
 
17. Did learning about these relatives help you better understand yourself in any 
way? 
18. Do you think that the sequencing and analysis of your data was accurate? 
19. Did you understand the results that you received?  
20. If yes, can you tell me more about how you used the results? Would anything 
have made them more usable?  
21. If no, can you tell me what may have helped you to better understand the 
results? A different type of reporting, educational videos, professional articles, 
professional consultation with an expert? 
22. Did you share the results with anyone, be it on the screen, in print, via email, etc? 
23. If yes, what made you want to share the data?  
24. How did you feel after you shared the data? 
25. Do you trust the company with your data? 
26. Who do you think should own the data, you or the company that provided the 
test? 
27. Do you have any concerns about the data being on public servers? 
28. How do you feel about your data being used for research? 
29. How would you feel it the company sold or turned over genetic data to marketing 
companies? 
30. How would you feel it the company sold or turned over genetic data to 
pharmaceutical companies? 
31. How would you feel it the company sold or turned over genetic data to insurance 
companies? 
32. How would you feel it the company sold or turned over genetic data to 
employers? 
33. How would you feel it the company sold or turned over genetic data to law 
enforcement? 
34. Do you think you should be compensated in some way if your data is sold or 
turned over to some other group or company? 
35. Did you know that you could download your raw genetic data? (Applies to some 
services only. Asking this depends on an earlier answer.) 
36. If yes, have you ever done it or do you think you would ever do that, and why? 
37. Do you think the government should regulate what types of test should be 
offered? 
38. Do you think the government should regulate what the company can do with your 
data? 
39. Is there anything I didn’t ask that you want to tell me? 
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You will be asked to participate in a health genomics interview and an 
observation session that will take approximately 1 hour to 1.5 hours. The interview and 
observation will be conducted via the internet using a conference voice line and a 
screen sharing application. During the interviews and observation session, we will ask 
for permission to record the audio and the video of the screen sharing software. Both 
the audio and video recordings will be used to create accounts of your expectations and 
experiences. Your identity will be kept completely confidential. Pseudonyms will be 
created and used for all individuals who participate in this research. Signed consent 
forms will be required to be signed prior to starting the research. The signed consent 
forms and analysis documents will be stored in separate locations. Video, audio, and/or 
still photos will be stored in a locked cabinet after it is recorded. Computer records will 
be password protected. The confidentiality of your individual information will be 
maintained in any publications or presentations regarding this study. 
1. How did you first learn about the concept of genetic tests for health? 
2. What did you think when you first learned about it?  
3. Can you tell me about the specific genetic tests you have taken in the past, 
including Sequencing.com as well as any other?  
4. Do you know if you had a whole genome test, exome test, gene panel, or SNP 
test? If yes, which one(s)? 
5. Are you generally interestested in Medical/Clinical (heart disease, cancer, etc), 
Wellness (sleep, diet, etc), or Lifestyle (taste preferences, ability to sprint vs. run 
long distances, etc) tests? 
6. How did you hear about that test(s)? 
7. What was your reaction when you learned about the test(s)? 
8. What made you interested in taking the test(s)?   
9. Did you have any specific goals or outcomes you wanted to achieve? 
10. Did you trust what you heard about the tests, be it verbally, in print, online, etc? 
11. Did you review the company's website? What did you think? 
12. Did you read any of the privacy policies or terms of use? If yes, what were your 
thoughts? 
13. What did you expect to learn from the test?  
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14. What was your reaction to the health analysis? 
15. How did you feel after the test? 
16. Did it help you better understand yourself and your health identity in anyway? 
17. Do you think that the sequencing and analysis of your data was accurate? 
18. Did you understand the results that you received?  
19. If yes, can you tell me more about how you used the results? Would anything 
have made them more usable?  
20. If no, can you tell me what may have helped you to better understand the 
results? A different type of reporting, educational videos, professional articles, 
professional consultation with an expert? 
21. Did you share the results with anyone, be it on the screen, in print, via email, etc? 
22. If yes, what made you want to share the data?  
23. How did you feel after you shared the data? 
24. Do you trust the company with your data? 
25. Who do you think should own the data, you or the company that provided the 
test? 
26. Do you have any concerns about the data being on public servers? 
27. How do you feel about your data being used for research? 
28. How would you feel it the company sold or turned over genetic data to marketing 
companies? 
29. How would you feel it the company sold or turned over genetic data to 
pharmaceutical companies? 
30. How would you feel it the company sold or turned over genetic data to insurance 
companies? 
31. How would you feel it the company sold or turned over genetic data to 
employers? 
32. How would you feel it the company sold or turned over genetic data to law 
enforcement? 
33. Do you think you should be compensated in some way if your data is sold or 
turned over to some other group or company? 
34. Did you know that you could download your raw genetic data? (Applies to some 
services only. Asking this depends on an earlier answer.) 
35. If yes, have you ever done it, or do you think you would ever do that, and why? 
36. Do you think a doctor / general practitioner should have been involved in 
administering the test or reviewing the data with you? 
37. Do you think a doctor / general practitioner is capable of reviewing the data? 
 




39. Do you think the government should regulate what the company can do with your 
data? 








You will be asked to participate in a health genomics interview and an 
observation session that will take approximately 1 hour to 1.5 hours. The interview and 
observation will be conducted via the internet using a conference voice line and a 
screen sharing application. During the interviews and observation session, we will ask 
for permission to record the audio and the video of the screen sharing software. Both 
the audio and video recordings will be used to create accounts of your expectations and 
experiences. Your identity will be kept completely confidential. Pseudonyms will be 
created and used for all individuals who participate in this research. Signed consent 
forms will be required to be signed prior to starting the research. The signed consent 
forms and analysis documents will be stored in separate locations. Video, audio, and/or 
still photos will be stored in a locked cabinet after it is recorded. Computer records will 
be password protected. The confidentiality of your individual information will be 
maintained in any publications or presentations regarding this study. 
1. What made you want to use sequencing.com specifically? (if not already 
answered) 
2. How did you first hear of sequencing.com? (if not already answered) 
3. How long have you been using sequencing.com? (if not already answered) 
4. Can you show me how you login to sequencing.com for me? 
5. If not social login, why not? 
6. If not 2 factor authentication, why not? 
7. Can you show me a quick overview of the dashboard and explain to me all of the 
elements on this page? 
8. Can you show me the apps you use and give me a brief overview of each? 
9. Can you show me how you browse for new apps and tell me about what you 
think of the process? 
10. Can you show me the apps you have used before and tell me if they met your 
expectation? 
11. Can you show me how you view results for apps and let me know what you think 
of this process? 
12. Can you show me a few reports and let me know if you understand everything in 
the report? If no, what might make you understand them more? 
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13. Can you show me how many times you have used the apps and let me know 
how you use this data? 
14. Can you show me how you seek out help if you need support when using 
sequencing.com, and let me know what you think of the help? 
15. Can you show me the altruist center, and let me know how you understand this 
area? What are your thoughts about it?  
16. Can you show me your altruist points, and let me know what you think of the 
points and how they make you feel? (only applies if they had already opted in. I 
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